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ABSTRACT
DEVELOPMENT OF NOVEL INKS AND APPROACHES FOR PRINTING
TISSUES AND ORGANS
by
Shen Ji
Tissue engineering is a multidisciplinary field that investigates and develops new methods
to repair, regenerate and replace damaged tissues and organs, or to develop biomaterial
platforms as in vitro models. Tissue engineering approaches require the fabrication of
scaffolds using biomaterials or fabrication of living tissues using cells. As the demands of
customized, implantable tissue/organs are increasing and becoming more urgent,
conventional scaffold fabrication approaches are difficult to meet the requirements,
especially for complex large-scale tissue fabrication. In this regard, three-dimensional (3D)
printing attracted more interest over the past decades due to its unrivaled ability to fabricate
highly customized tissues or scaffolds from patients’ medical images using computer aided
design (CAD), as well as its flexibility, cost-effectiveness, and high efficiency. And more
recently, 3D bioprinting can fabricate cellular constructs using a “bioink”, an aqueous
composite formulation that contained live cells as a mandatory component, which is a big
step towards functional organ fabrications.
However, to fully realize the potential of 3D (bio)printing in tissue engineering,
there are still a lot of barriers before implantable artificial organs, including but not limited
to vascularization of fabricated tissue/organs, multicellular biofabrication, limited
functional biomaterial, and dynamic maintenance/remodeling. To address some of these
problems, this dissertation aims to develop novel inks and approaches for printing tissue
and organs. Firstly, a novel bioprinting approach is developed to create user-defined

complex perfusable channels within cell-laden hydrogels, which uses commercially
available bioprinters, hydrogels, and open-source software. The printing process is cellfriendly, and the channels could be further endothelialized to make the cell-laden hydrogel
a vascularized tissue. Secondly, novel bioinks from UV-responsive norbornenefunctionalized carboxymethyl cellulose macromers are developed. The cost-effectiveness,
tunability, degradability, and cytocompatibility make this bioink platform a good addition
to the current available bioink library. Thirdly, considering the demands of fabricating hard
degradable scaffolds for bone tissue engineering, a polyester-based ink platform with
tunable bioactivity is developed. Functionalized 3D printed scaffolds show a significant
impact that enhanced the osteogenesis of human stem cells. Finally, the impact of the
architectures of the 3D printed scaffolds on stem cell differentiation is investigated, which
demonstrated enhanced osteogenesis of human stem cells on scaffolds with wavy
architectures, compared with on scaffolds with orthogonal architectures.
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CHAPTER 1
INTRODUCTION

1.1 3D Printing Technologies for Tissue Engineering and Regenerative Medicine
Tissue engineering is a multidisciplinary field currently focused on two major areas: (i)
developing new methods to repair, regenerate and replace damaged tissues and organs, and
(ii) creating in vitro tissue models to better understand tissue development, disease
development and progression, and to develop and screen drugs [1-6]. Despite recent
advances in tissue engineering, there is a continuous lack of tissues and organs for
transplantation and a shortage of tissue models for drug discovery and testing [7].
Conventional

techniques,

such

as

porogen-leaching,

injection

molding,

and

electrospinning, are generally recognized as the bottleneck due to limited control over
scaffold architecture, composition, pore shape, size, and distribution [8-10]. 3D bioprinting
is an emerging field enabling fabrication of scaffolds, devices, and tissue models with high
complexity [9-12]. 3D printing allows the construction of tissues or scaffolds from
commonly used medical images (such as X-ray, magnetic resonance imaging (MRI), and
computerized tomography (CT) scan) using computer aided design (CAD). Custom and
patient-specific design, on-demand fabrication, high structural complexity, low-cost, and
high-efficiency are some of the major advantages of 3D printing, making it very attractive
for medicine [13, 14].
Tissue engineering scaffolds are three-dimensional porous structures providing an
infrastructure for cells to infiltrate, adhere, proliferate, and enabling new tissue formation
for functional integration [1]. Scaffolds are generally required to display bioactivity to
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instruct cellular behavior, such as adhesion, proliferation, migration, and differentiation [3].
In addition, control over composition, stiffness, degradation, and structural architecture are
required as cells are responsive to their microenvironment [3, 15]. In vitro tissue models
require the ability to fabricate cell only or cell-biomaterial platforms that mimic cellular
organization (spatial distribution of multiple cell lines) and microenvironment (stiffness,
structural topography, and biochemical cues) in relatively high resolution (25-100 μm) [2,
4, 5, 16, 17]. 3D printing has the potential to fabricate these complex platforms.

1.2 3D Bioprinting and 3D Printing of Biomaterials
Tissue engineering approaches require the fabrication of scaffolds using biomaterials or
fabrication of living tissues using cells. 3D printed scaffolds can be utilized directly,
allowing native cells to infiltrate and regenerate the tissue when implanted, or after seeded
with cells. The printable material is referred as a “biomaterial ink.” Currently available 3D
printing technologies allow a wide range of biomaterials to be printed using diverse
biomaterial ink formulations [13]. 3D printing technologies for biomaterial printing are
classified under four main groups in this work: extrusion-based, droplet-based, powderbased, and vat photopolymerization-based printing. Extrusion-based printing technologies
include fused filament fabrication (FFF) or known as under trademark fused deposition
modeling (FDM), and direct ink writing (DIW). FDM utilizes synthetic thermoplastics and
their composites with ceramics or metals [18]. For FDM, the form of the ink material is a
filament, and it is extruded at elevated temperatures (140-250 ℃) in a melt state. Direct
ink writing (DIW) allows extrusion of polymer melts, high viscosity solutions, hydrogels,
and colloidal suspensions [19]. Inkjet printing is a droplet-based technology, and the
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processing principle is the deposition of polymeric solutions and colloidal suspensions,
with relatively low viscosities (< 10 cP (mPa.s)) at relatively high shear rates (105-106 s-1)
in the form of droplets (~50 m in diameter) [20-23]. Selective laser sintering (SLS)
utilizes metals, ceramics, polymers, and composites in powder form (10-150 μm in
diameter). In this technique, a directed laser beam locally melts either directly the powder
or a polymeric binder onto the bed surface [24]. Layers of fresh powder are continuously
supplied after each layer is created. Binder jetting is another powder-based printing
technology, which jets binder polymers to selectively bond powder materials into 3D green
bodies, followed by infiltration or sintering to achieve final products [25]. The vat
photopolymerization approaches require a viscous photocurable polymer solution or a
prepolymer, which is exposed to a directed light (such as UV or laser) to spatially crosslink
the solution [26].
Three dimensional bioprinting is a technology that allows the fabrication of living
tissues/constructs from living cells with or without a carrier material [9-11, 27, 28]. The
material that is printed is referred to as a “bioink”, which can be defined as an ink
formulation that allows the printing of living cells. 3D bioprinting process should be
relatively mild and cell-friendly as it is required to allow cell printing [29]. This
requirement limits the number of 3D printing techniques that are suitable for bioprinting.
DIW allows the printing of cell suspensions and/or aggregates with or without a hydrogel
carrier. Inkjet printing is another technology for cell printing. As compared to DIW, inkjet
bioprinters are not readily available, yet there are commercially available inkjet print heads
that are suitable for bioprinting [30, 31]. Vat photopolymerization-based 3D printing
technologies, such as SLA, digital light processing (DLP), and continuous digital light
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processing (cDLP), have emerged in printing live cells as long as a cell-laden prepolymer
formulation is used and the photocuring takes place in a mild, cell-friendly condition,
which are the two major issues for vat photopolymerization-based bioprinting [32-34]. In
addition to these technologies, laser induced forward transfer (LIFT) is also shown to be
suitable for bioprinting [35-40]. In this technique, an ink solution is coated onto a glass
slide and coated with a laser absorption layer (metal or metal oxide). The laser is directed
to the laser absorption layer with an ablation spot size between 40 to 100 μm in diameter
[35, 37], creating a local pressure to eject the ink layer to the substrate.

Figure 1.1 Different Types of 3D Printing Technologies.
Source: Adapted with permission [41], copyright 2016, American Chemical Society.

Among 3D printing techniques, extrusion-based printing is the most commonly
used technology due to ease of use, availability, and low cost. In this regard, this
dissertation is focusing on developing novel inks for extrusion-based biomaterial printing
and bioprinting as well as developing novel bioprinting approaches using DIW bioprinting.
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1.3 Currently Available Bioinks and Biomaterial inks
Noticeably, many of the biomaterial ink formulations are not suitable for cell printing. For
instance, polycaprolactone (PCL) and poly(lactic acid) (PLA) are the most widely used
biomaterials in 3D printing. However, they could only be printed at elevated temperatures
in the form of a polymer melt, or when dissolved in organic solvents as a polymer solution.
Therefore, they are not considered as bioinks, as both approaches are not suitable for live
cell printing [42, 43].
Currently, cell-laden hydrogels (also known as scaffold-based bioinks) and cellonly bioinks (also known as scaffold-free bioinks) are the two major types of bioinks
(Figure 1.2) [44-46]. Cell-laden hydrogels are particularly attractive due to their tunable
properties and their ability to recapitulate the cellular microenvironment [47]. Cell-laden
hydrogel bioink formulations utilize natural hydrogels such as agarose, alginate, chitosan,
collagen, gelatin, fibrin, and hyaluronic acid, as well as synthetic hydrogels such as
poly(ethylene glycol) (PEG) and its derivatives. Natural hydrogels offer inherent
bioactivity (except for agarose and alginate) and display a structural resemblance to ECM.
For instance, fibrin and collagen hydrogels with inherent filamentous structure display
strain-stiffening property, mimicking the non-linear elastic behavior of the soft tissues in
our body [48, 49]. Synthetic hydrogels permit but don’t promote cellular function, yet there
are many ways to tether bioactive cues into synthetic hydrogels [15]. When compared to
natural hydrogels, synthetic hydrogels generally offer tunable mechanical properties. Many
natural polymers (such as gelatin and hyaluronic acid) have functionalizable backbone side
chains enabling them to be functionalized with chemical moieties to induce crosslinking
(chemical- and/or photo-crosslinking) or additional bioactivity [50]. Blends of synthetic
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and natural polymers have been used to develop mechanically tunable hydrogels with userdefined bioactivity. In addition, the mechanical properties and/or bioactivity can also be
tuned by incorporating small amounts of nanoparticles into bioink formulation [51].
Derived from native tissues by removing the cells from the tissue while retaining the native
extracellular matrix (ECM) ingredients, decellularized extracellular matrix (dECM)-based
bioink formulations are an emerging field due to their inherent bioactivity and ease of
formulation into a printable bioink [52, 53]. The compositions of dECM-based bioinks are
more comprehensive than the others, which contains a tissue-specific complex composition
of structural and functional ECM components of native tissue, such as collagen,
glycosaminoglycans (GAGs), and growth factors [53-56]. This unique advantage makes
dECM-based bioinks a good candidate for 3D bioprinting of tissue constructs [52, 57-59].
On the other hand, cell-only bioinks, including cell suspension, cell spheroids, and
cell strands, are a viable option to create scaffold-free biological constructs [60, 61].
Modified inkjet printers have long been used to print cells into cellular assemblies. For
instance, endothelial cells were printed from cell suspension (1 × 105 cells/ml) in growth
media [62]. Bioprinting of scaffold-free constructs utilizes cell aggregates in the form of
mono- or multi-cellular spheroids as a bioink [23, 63-65]. The bioink formulation
undergoes fully biological self-assembly without or in the presence of a temporary support
layer [63]. This technique relies on tissue liquidity and fusion, which allows cells to selfassemble and fuse due to cell-cell interactions [66-68]. Recently, due to the advantage of
freeform bioprinting, pelleted cells were directly printed within a support bath in 3D
structures [69].
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Figure 1.2 Examples of currently available bioinks: (A) an explanted embryonic chick
heart bioprinted with cell-laden hydrogel: (i) darkfield image, and (ii) a confocal
microscope image of the chick heart stained for fibronectin (green), nuclei (blue), and Factin (red). (scale bar: 1 mm).; (B) A heart bioprinted with personalized cell-laden dECMbased hydrogel: (i) visualizing the left and right ventricles of the heart by injecting red and
blue dyes, and (ii) a confocal image that visualized the bioprinted cardiomyocytes (pink),
and endothelial cells (orange) (scale bar: 1 mm); (C) bioprinting of cell-only bioink (cell
spheroids): (i) to (iii): bioprinted cellular patterns with cell spheroids, and (iv) stacking cell
spheroids without supports.
Source: Adapted under the terms of the CC-BY 4.0 license [70]. Copyright 2015, the Authors. Published by
American Association for the Advancement of Science.
Adapted under the terms of the CC-BY 4.0 license [59]. Copyright 2019, the Authors. Published by John
Wiley and Sons
Adapted under the terms of the CC-BY-NC 4.0 license [71]. Copyright 2020, the Authors. Published by
American Association for the Advancement of Science.

As to biomaterial inks, thermoplastic biomaterial inks, hydrogel inks, ceramicbased inks, and composite inks are currently available [41]. Thermoplastic biomaterials are
the most commonly used in 3D printing of scaffolds, especially for desktop 3D printers, as
a result of the ease to be processed, cost-effectiveness, biocompatibility, degradability, and
mechanics. Thermoplastics could be engineered to be printed by extrusion-based (FDM
and DIW), powder-based (SLS), and vat polymerization-based (SLA, DLP, cDLP) 3D
printing techniques. Each of these techniques requires different material properties. For
FDM and DIW at high temperatures, thermoplastics must render a rapid solid-to-melt
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transition to secure melt formation pre-extrusion and solidification post-extrusion, whereas
shear thinning properties of the melt are also required [18]. Specifically, for FDM, the
value of the elastic modulus/melt viscosity should be lower than 5×105 s-1 to prevent
filament buckling. In this regard, many thermoplastic biomaterials are available for high
temperature FDM/DIW printing, including but not limited to PLA [72], PCL [73],
polyether ether ketone (PEEK) [74], poly(butylene terephthalate) (PBT) [75], acrylonitrile
butadiene styrene (ABS) [76], thermoplastic poly(urethane) (TPU) [77], and thermoplastic
composite materials [78]. Unlike FDM, in which the ink must be in a filament form, DIW
can print polymer solutions and hydrogels at low temperatures. The printable polymer
solutions are typically comprised of volatile organic solvents, such as dichloromethane,
chloroform, and tetrahydrofuran, which permits rapid dissipation within seconds after
extrusion. Moreover, thermoplastic particles could be suitable for SLS, which requires the
particle diameters in the range of 10-150 μm to permit good flowability and print resolution,
and the melt viscosity should be low as well [79]. Finally, thermoplastics, such as
poly(D,L-lactide) (PDLLA) [80] and poly(propylene fumarate) (PPF) [81], are also
available for vat polymerization-based 3D printing (SLA, DLP, cDLP).
Hydrogel inks are also great candidates for DIW, which has been mentioned in the
bioink sections. Besides, sacrificial hydrogels such as Pluronic F-127 (Pluronic) render
excellent printability and fidelity, which is commonly used as support material during
bioprinting processes [82]. Ceramic-based inks are also of great significance, especially
for bone tissue engineering, due to their high stiffness and bioactivities [83].
Hydroxyapatite and tricalcium phosphates (TCP) are two major ceramic biomaterials used
in bone tissue engineering. Due to the high melting point and processing difficulty, it is
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convenient to mix ceramic biomaterials with polymers to formulate composite inks for 3D
printing [84, 85]. Ceramic inks are also available to be printed in bulk forms by binder
jetting of SLS [25, 86, 87]. As pure materials often fail to render all the desired properties,
single material inks have been formulated with other materials as composite inks to
enhance ink properties, which includes polymer-based, hydrogel-based, and ceramic-based
composites. For instance, PCL could be supplemented by hydroxyapatite/TCP and growth
factors to enhance the osteogenic function of the 3D printed scaffolds [88].

Figure 1.3 Distinction between a bioink (left side) in which cells work as a mandatory
component, and a biomaterial ink (right side), where a biomaterial is used to print a scaffold
for cell seeding.
Source: Adapted under the terms of the CC-BY 3.0 license [89]. Copyright 2018 IOP publishing.
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1.4 Complex 3D Bioprinting
3D bioprinting technology already enabled the fabrication of small-scale tissues [5, 90, 91],
and in the short-term, these bioprinted tissues could potentially address the lack of
functional in vitro tissue/disease models for personalized medicine and drug screening. In
the long-term, bioprinting show strong potential to address the shortage of implantable
organs [27, 92]. To achieve these short- and long-term goals, it is crucial to capture the
architectural, structural, mechanical, and biochemical complexity of the native tissue. This
requires the bioprinting process to evolve from small-scale, low-resolution, single or dual
cell and biomaterial printing to human-scale, high-resolution, multi-cellular, and multibiomaterial printing [93-95]. For complex 3D bioprinting, two aspects of complexities of
the printed tissue/organ constructs are usually considered to resemble in vivo conditions,
including the tissue architecture and the physical (stiffness) and biochemical (cells and
bioactive cues) complexity. Due to layer-by-layer fabrication, 3D printing of complex
architectures such as tubular and spiral as well as hollow structures (such as embedded
channels for vascularization) is limited. Native tissues are multicellular that compromise
many cell types, which requires the ability to formulate and bioprint multiple cell types
while maintaining their phenotype or derive them into site-specific lineages. To resemble
the physical and biological complexity, it is crucial to place a multitude of bioinks within
a 3D space allowing precise distribution of multiple cell types and ECM mimetic materials.
Besides, the fabrication of vascular networks that are embedded within the bioprinted
tissues is one of the key issues to achieve large-scale bioprinting, as vasculature is crucial
for nutrient supply and waste removal to overcome mass transfer limitations [96, 97].
Recent advances in bioprinting technology and bioink development enabled to
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overcome some of the abovementioned issues (Figure 1.4). For instance, 3D printing
integrated with gel-casting is one of the widely used strategies for the fabrication of channel
structures embedded within 3D cell-laden hydrogels (Figure 1.4A) [98-104]. This
approach includes mold fabrication, 3D printing of sacrificial structures within the mold,
hydrogel precursor solution casting into the mold followed by hydrogel crosslinking, and
finally removal of the sacrificial structure. Another convenient approach is 3D bioprinting
with support materials (Figure 1.4B) [52, 58, 82, 105-107]. By printing a sturdy framework
of support material along with the bioinks, the bioprinted tissue construct becomes selfsupportive. The support ink can be a sacrificial hydrogel such as Pluronic, which can be
removed after printing, or a thermoplastic (such as PCL and polyurethane (PU)) that can
remain to provide mechanical stability for the bioprinted structure both in vitro and in vivo.
In addition, the approach is efficient for bioprinting straight tubular structures in
macroscale (Figure 1.4C). In the unit-stacking approach, cell-laden hydrogels are
bioprinted as cylinders or spheroids, which serve as the building units that can be stacked
into the desired shape or a construct [63, 108-112]. Moreover, Coaxial bioprinting is
suitable for the continuous fabrication of tubular structures (Figure 1.4D). The key feature
of coaxial bioprinting is the 2-layered nozzle, which enables co-extrusion of two different
bioink formulations in a core-shell manner [113-115]. Due to the ease of direct bioprinting
of tubular channels, researchers formulated endothelial cell-laden bioactive bioinks to
fabricate thick, vascularized, functional tissues [57, 116-120], and recent studies showed
coaxial bioprinting of heterogenous and hallow filaments enabling fabrication of complex
tissue constructs [121-124]. However, the layer-by-layer printing process significantly
limits the achievable complexity of the microstructures and 3D anisotropy as well as the
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ability to print tissue mimetic soft hydrogels (elastic modulus below 100 kPa) or cells alone.
Freeform extrusion-based bioprinting overcomes these issues by eliminating the need for
layer-by-layer fabrication and enabling omnidirectional freeform fabrication (Figure 1.4E)
[125]. In this approach, DIW is performed within a support bath which physically supports
the printed structure. The ink is extruded out of a needle-like nozzle that moves through a
support bath, deposited within the bath, and held in place [59, 70, 126-130]. Last but not
least, vat photopolymerization-based printing approaches have gained recent attention due
to their ability to create support-free complex structures and omnidirectional printing
(Figure 1.4F). In particular, light-assisted printing using projection, including DLP and
cDLP, attracted more interest due to enhanced print speed as compared to SLA [34, 131144].
Although the abovementioned techniques enable complex bioprinting, yet there is
still more to accomplish to achieve the fabrication of fully functional, human-scale, and
highly-complex tissues and organs.
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Figure 1.4 The evolution of complex bioprinting: (A) 3D printing integrated with gelcasting; (B) 3D bioprinting with support materials; (C) unit-stacking approach; (D) coaxial
bioprinting; (E) Freeform bioprinting; (F) Light-assisted bioprinting.

1.5 Objectives
In this dissertation, two main objectives are presented:
Objective 1. To develop a novel bioprinting approach to create complex microchannels
within cell-laden hydrogels.
Objective 2. To extend the range of available inks for tissue engineering applications
Objective 2.1. To develop novel bioinks from UV-responsive norbornenefunctionalized carboxymethyl cellulose macromers
Objective 2.2. To develop a functional polyester-based ink platform with the
potential for tunable bioactivity
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1.6 Dissertation Organization
In Chapter 2, a novel 3D bioprinting approach is developed to create complex
microchannels within cell-laden hydrogels, which utilized photocurable and sacrificial
hydrogels.
In Chapter 3, novel bioinks from UV-responsive norbornene-functionalized
carboxymethyl cellulose macromers are developed, where the formulation, rheological
properties, printability/printing process, and cell viability were investigated.
In Chapter 4, a novel functional polyester-based ink platform with tunable
bioactivity was developed, which has promising rheological, mechanical, and biological
properties towards 3D printing of tissue engineering scaffolds for bone regeneration.
In Chapter 5, 3D porous scaffolds with wavy or linear patterns were printed to
investigate the effect of wavy scaffold architecture on hMSC osteogenesis.
In Chapter 6, the summary and conclusion of this dissertation are provided. And
the future work directions are envisioned.
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CHAPTER 2
3D BIOPRINTING OF COMPLEX CHANNELS
WITHIN CELL-LADEN HYDROGELS
This chapter has been adapted from the publication:
S. Ji, E. Almeida, M. Guvendiren, 3D bioprinting of complex channels within cell-laden
hydrogels, Acta Biomaterialia 95 (2019) 214-224.

2.1 Introduction
The advances in additive manufacturing technologies enabled the fabrication of complex
3D scaffolds and medical devices [9, 27, 28, 82, 145, 146]. To fabricate clinically relevant
and human scale tissue and organs, development of 3D constructs with vascular networks
is one of the major bottlenecks [96, 147-149]. Thus, there is a growing demand for novel
approaches to create perfusable microchannels, with tunable sizes and shapes, within 3D
printed hydrogel constructs. Hydrogel constructs with embedded microchannels are also
essential for the development of organ-on-a-chip systems for fundamental studies relating
to tissue development and disease, and potentially be useful for drug testing [150].
Besides 3D bioprinting, various approaches were reported to fabricate tubular
vessels, porous constructs, and microchannels to develop vascular structures, including
solvent-casting and particulate leaching [151-153], gas foaming [154], fiber bonding [155],
phase separation [156, 157], electrospinning [158], and self-assembly/healing [159, 160].
Yet, 3D bioprinting offers many advantages, including precise control of channel size,
shape, and location (within the construct), and the ability to print multiple-materials
including cells and cell-laden hydrogels [161].
In the past decade, several strategies have been developed to create microchannels
within 3D printed constructs. Gel-casting on a 3D printed sacrificial network is a
convenient approach to fabricate embedded microchannels within hydrogels [98-101]. In
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this approach, a curable hydrogel solution is casted on a 3D printed sacrificial template
(scaffold) using a mold. A wide range of sacrificial ink materials have been used (agarose,
gelatin, Pluronic, and sugar-based materials) to create microchannels [98-100, 162-164].
For example, Miller et al. reported the use 3D printed sugar-based inks to fabricate
sacrificial (e.g., water-soluble) templates (scaffolds), and were able to fabricate a range of
constructs (from curable hydrogels) with embedded channels, with diameters ranged from
150 μm to 800 μm [98]. Lewis group utilized a similar approach to fabricate hydrogels
with vascularized, perfusable channels (using water-soluble Pluronic) that can support
encapsulated cell growth for more than 6 weeks [100]. Although this approach is shown to
be efficient in creating embedded microchannels within hydrogels, it is almost impossible
to place channels at a user-defined height unless multiple printing (of sacrificial material)
and gel-casting steps are introduced. Another approach is free-form bioprinting, which
refers to direct printing of a material (e.g., hydrogel ink) into a support bath (e.g., hydrogel)
using extrusion-based printing [70]. In this approach, the support bath can be filled either
with a sacrificial material, in which case it will be removed after the printing of a matrix
material, leaving out a self-supporting matrix, or with a stable matrix material, in which
case a sacrificial material is printed within and removed after printing to create channels
[70, 130, 165-169]. Independent of the particular approach (i.e., self-supporting matrix
printing within support material or channel printing within matrix material), the bath
material has to allow the needle motion during printing. In this regard, highly viscous
polymer slurries, salt solutions, shear-thinning hydrogels, and micro-gels have been
utilized [70, 130, 165-168]. This requirement significantly limits the number of available
materials

for

this

approach.

In

addition
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to

extrusion-based

printing,

vat

photopolymerization printing was also utilized. Stereolithography was used to spatially
cure photocurable hydrogels within vat to create embedded channels within hydrogels [132,
170-172].
In addition to the abovementioned approaches, “unit stacking” and “co-axial
printing” approaches have also been utilized to develop vessels (or hollow tubes). In the
unit stacking approach, cell spheroids were loaded in agarose hydrogel and printed to form
a filament and supported by agarose only filaments. This technology enabled the
fabrication of small vessel tubes that are 0.9-2.5 mm in diameter [63]. Byambaa et al.
utilized “unit stacking” approach using GelMA hydrogels [112]. In this method, each
GelMA strut is printed individually layer-by-layer on the building plane. To form channels,
a sacrificial ink is printed, using a secondary print head, to replace one of the GelMA struts.
This is the most commonly used bioprinting approach in the literature to fabricate channels.
The advances in additive manufacturing technologies enabled the fabrication of complex
3D scaffolds and medical devices [9, 27, 28, 82, 145, 146]. To fabricate clinically relevant
and human scale tissue and organs, the development of 3D constructs with vascular
networks is one of the major bottlenecks [96, 147-149]. Thus, there is a growing demand
for novel approaches to create perfusable microchannels, with tunable sizes and shapes,
within 3D printed hydrogel constructs. Hydrogel constructs with embedded microchannels
are also essential for the development of organ-on-a-chip systems for fundamental studies
relating to tissue development and disease and potentially be useful for drug testing [150].
Although many approaches have been developed (as summarized above), there is
still a need for novel approaches that are easily applicable, allowing the use of
commercially available bioinks and desktop bioprinters to create user-defined and tunable

17

microchannels within 3D hydrogels. In this study, we address this gap. Here, a novel
bioprinting approach is presented that enables 3D printing of user-defined and highly
tunable channels (shape, size, and location within matrix hydrogel) embedded within a
photocurable hydrogel matrix. In this approach, a photocurable hydrogel ink was printed
layer-by-layer as usual, but partially photocrosslinked (for seconds) after the printing of
each layer to allow self-supporting viscous construct. When the desired height was reached,
the final matrix hydrogel layer was not exposed to light and s sacrificial hydrogel (Pluronic)
was directly printed within this layer. The layer was then exposed to light to partially
crosslink the matrix hydrogel and to confine Pluronic. This process was repeated as needed.
Once the printing of the construct was finalized, it was exposed to light (minutes) to fully
crosslink the construct and immersed in an aqueous solution to remove the sacrificial ink
to form channels. Here, an important advance is reported as this approach does not require
complex device modifications for bioprinters or complex synthesis and processing hurdles
for the inks. It is also a reservoir and mold free (utilizes low amount of material) and allows
flexibility to place channels at any height within the matrix. This approach allows
bioprinting of cells with the matrix material and seeding of cells into channels after the
sacrificial ink is removed. It could be envisioned that this approach can provide a robust
platform for fabricating vascularized tissues and studying cell behaviors on diverse channel
surfaces and will enable wide-spread use of bioprinting to create microchannels within
hydrogels.
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2.2 Materials and Methods
2.2.1 Polymer Synthesis
Methacrylated alginate (MeAlg) and methacrylated hyaluronic acid (MeHA) were
synthesized by esterification of the hydroxyl group with methacrylic anhydride, following
already established protocol [173, 174]. Briefly, 1 % (m/v%) polymer solution was
prepared by dissolving 3 grams of low viscosity alginate (Alg, Alginic acid sodium salt
from brown algae, Sigma) or sodium hyaluronate (HA, 60 kDa, Lifecore) in 300 mL
deionized water in a three-neck flask. The solution was stirred and kept at ~1-4 °C in an
ice bath. Subsequently, a 2M NaOH solution was used to adjust the pH of the polymer
solution to 8-9. Then, 6 mL of methacrylated anhydride (MA, Sigma) was added dropwise
to the 1% polymer solution, while 4M NaOH was simultaneously added to maintain the
pH at 8-9. The whole amount of the MA was consumed with a span of 1.5~2 hours. After
the addition of the MA, the pH was maintained by gradually pipetting 4M NaOH solution
for 8 hours using an automated pH controller. The solution was kept at 4 °C overnight. The
reaction was resumed the following day by adding 3mL of MA while maintaining the pH
at 8-9. The material was then dialyzed (Spectra/Por®1 dialysis membrane, 6-8 kDa) against
DI water for 4 days, followed by lyophilization. The percent modification was
characterized using 1H NMR.
2.2.2 Ink Preparation
Ink formulations were prepared by dissolving MeHA (or MeAlg) at different
concentrations in phosphate-buffered saline (DPBS) in the presence of a photoinitiator
(405-410 nm), lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP). For instance, to
prepare a 9% MeAlg, 0.001 g of LAP was dissolved in 2 ml of DPBS in a glass vial covered

19

with an aluminum foil. 0.18 g of MeAlg was then added into the solution, and the solution
was stirred overnight at room temperature. Considering the previous reports [165], three
different concentrations were used for MeAlg (5%, 7% and 9% (w/v)) and for MeHA (5%,
10%, and 15% (w/v)). Sacrificial ink, Pluronic F-127 (Sigma), was prepared by dissolving
4 g Pluronic in 10 ml of deionized water (40% (w/v) final solution) at 4 °C overnight.
To prepare cell-laden ink, 1 ml of 18% MeAlg (or 30% MeHA) was mixed with
20 μL RGD peptide (50 mg/mL, GRGDSPC - GenScript) and incubated at room
temperature (RT) for 30 min. Then, the solution was mixed with 1 mL of cell suspension
(hMSC, 2×106 cells/mL) under magnetic stirring, leading to a final concentration of 9%
MeAlg (or 15% MeHA). Each ink formulation was transferred into a designated 10 mL
syringe prior to printing.
2.2.3 Rheological Characterization of Ink Formulations
Malvern Ultra+ Rheometer was used to analyze the rheological properties of the ink
formulations. All of the tests were performed using a flat plate geometry (20 mm) at 25 °C.
For viscosity measurement, the shear viscosity was measured at shear rates from 0.01 to
1000 s-1. Time sweep tests were done at a frequency of 1 Hz and an oscillatory strain of
0.05 to investigate the change in elastic modulus (G’), viscous modulus (G’’), and phase
angle (Φ). To investigate the evolution of the abovementioned rheological parameters
during the 3D printing process, inks (9% MeAlg or 15% MeHA) were injected onto the
lower plate of the rheometer, and time sweep tests were performed using a UV light
apparatus (Malvern) connected to a UV light source (Omnicure S2000, 356 nm,
40 mW/cm2). Light intensity was adjusted to compensate for the difference in the
wavelength of the printer light source (405 nm) according to the molar absorptivity
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spectrum of the photoinitiator (LAP) [175]. The ink was exposed to UV light in a stepwise
manner mimicking the partial crosslinking (240 s for 9% MeAlg, 5 s for 15% MeHA) and
fully crosslinking (15 s for 9% MeAlg, 90 s for 15% MeHA).
2.2.4 Printer Parameter Optimization (Line Test)
Ink formulations were used to print individual struts (lines) on a methacrylated glass slide
at different pressures and speeds. The images of struts were captured by a microscope.
Three random parts of each strut (from three samples per each group) were captured for
analysis. The strut diameter was measured using ImageJ.
2.2.5 Scaffold Design
3D scaffold designs were created by Autodesk® Fusion 360™ and sliced with Slic3r in
Repetier-Host to generate G-code files. For scaffolds with embedded channels, the matrix
and the channel structures were sliced separately. The G-code file for the channel design
was then incorporated into the G-code file for the matrix design.
2.2.6 Preparation of Methacrylated Glass Slides
In this study, surface modified glass slides (microscope slides) were used as the print
substrate. The glass slides were modified with methacrylate as described previously [176].
Briefly, glass slides were first washed with DI water, then immersed in a 10M NaOH
solution for 10 minutes. Subsequently, the glass slides were removed and washed with DI
water, and dried. Glass slides were placed in a glass baking pan, and the surface of the glass
slides were covered with 3-(Trimethoxysilyl)propyl methacrylate (TMS, Sigma) solution.
After sealing the top of the pan with aluminum foil, the pan was put into an oven at 100 °C
for 1 hour. After 1 hour, the temperature was increased to 110 °C for another 10 minutes.
The glass slides were then washed with ethanol and rinsed with DI water and dried.
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2.2.7 3D Printing of Sacrificial Hydrogel within the Matrix Hydrogel
A novel approach was developed to 3D print vasculature within cell-laden hydrogels. Our
approach utilizes 3D printing of a sacrificial hydrogel (or polymer) within the freshly
printed matrix layer. Our approach is summarized in Figure 2.1. Briefly, the matrix ink
(MeHA or MeAlg) was printed layer-by-layer as usual. After each layer, the construct was
exposed to light to partially cure the printed matrix hydrogel (405 nm, 40 mw/cm2, 15 s for
9% MeAlg and 5 s for 15% MeHA), which formed a self-supporting layer. Each layer was
usually in the range of 500-600 μm but adjusted by adjusting the print speed or pressure of
the matrix ink. When the desired matrix thickness was reached, one additional layer was
printed, but it wasn’t exposed to light. The sacrificial ink was printed directly within this
viscous layer, and the system was exposed to light. This process was repeated as required
to complete the printing process. Once the printing of the desired construct was completed,
the system was exposed to a final light exposure to fully crosslink the construct (405 nm,
40 mw/cm2, 240 s for 9% MeAlg and 90 s for 15% MeHA). The construct was then
immersed in an aqueous media (i.e., DPBS) to dissolve the sacrificial ink and form
channels. A wide range of print speed and pressure was used for sacrificial hydrogel
printing to investigate the effect of these parameters on strut size. The sacrificial matrix
strut size was measured prior to the dissolution of the matrix, and the results were compared
with the measured channel diameter. Channels were injected with red food coloring for
visual clearance. Three random parts of each strut/channel (from three samples per each
group) were captured for analysis. The strut/channel diameter was measured using ImageJ.
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2.2.8 Cell Culture and Characterization
Human mesenchymal stem cells (hMSCs, passage 4, Lonza) were cultured in the growth
media (α-MEM (minimum essential medium) supplemented with 10% fetal bovine serum
(FBS, Gibco) and 1% penicillin-streptomycin (Gibco)). For hMSC-laden bioink studies,
two scaffold groups were printed including scaffolds with channels and without channels
(control group). Scaffolds were cultured for 4 days, and live-dead staining was done at Day
1 and Day 4 time points. For live-dead staining (Invitrogen), cells were stained with
calcein-AM (“live”, 0.5 μL/mL) and ethidium homodimer (“dead”, 2 μL/mL) for 30
minutes. Samples were immediately transferred to confocal laser scanning microscope
(confocal and 2-photon scanning microscope, Leica) after staining to capture 3D scans.
Three samples per group was prepared for viability studies. The viability was calculated
by counting cells using ImageJ.
Human umbilical vein endothelial cells (HUVECs, Lonza) were cultured for cell
attachment studies on the channel surfaces. According to the vendor’s protocol, HUVECs
were cultured in EGM-2 media (EGM-2 BulletKit, Lonza). Media was changed every two
days to ensure a proper cell proliferation. Cells with 4-6 passage number were used in this
study. Prior to the seeding process, the channels were injected with fibronectin (Invitrogen)
solution (50 μg/mL) to enhance cell attachment. Cell suspension (3×107 cells/ml) was
injected into the channels using a micropipette (0.1-10 μL tip). Scaffolds were then
incubated at 37 ºC for 2 h, during which the scaffolds were flipped every 30 min. Scaffolds
were then cultured for 7 h (during which they were flipped back one more time after the
first 2 h), followed by culture on an oscillating shaker at a frequency of 1 Hz. The nonadherent cells were flushed out of the channels by gently pipetting the media. The media
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was changed every two days. The cell culture studies were performed in an incubator
maintained at 37 ºC under 5% CO2. Cells in the channels were observed with a fluorescent
microscope. At Day 14, the channels were gently flushed with DPBS (3X), and cells were
fixed with 4% formaldehyde. Cells were permeabilized with 0.25% Triton-X (Sigma) and
stained with Alexa Fluor™ 488 Phalloidin (Invitrogen) and with DAPI (Sigma) for F-actin
and nuclei, respectively.
2.2.9 Statistical Methods
If not stated specifically, three samples per each group were used for all studies. The data
were analyzed using KaleidaGraph. Data are presented as mean ±standard deviation.
ANOVA with Tukeys HSD post hoc test of means was used to make comparisons between
sample groups.
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PRINTING APPROACH

Matrix Layer 1

Matrix Layer 2

Sacrificial Hydrogel

Partial Curing

Matrix Layer 3
Partial Curing

Partial Curing

Matrix Ink
Sacrificial Ink
Light Source

Dual Print-head
with light source

POST-PRINTING PROCESS

Immerse in PBS
Full Curing

Dissolution of sacrificial
layer leads to channels

Figure 2.1 Schematic showing the novel printing approach to create complex channels
embedded within photocurable hydrogels, including sequential printing of a photocurable
matrix hydrogel and a sacrificial hydrogel within freshly printed matrix hydrogel layer,
followed by a post-printing process to remove the sacrificial hydrogel to create channels.

2.3 Results
2.3.1 Preparation and Characterization of Inks
Ink formulations were prepared from MeAlg and MeHA, with 90 % and 72 %
methacrylation, respectively (Appendix A, Figure A.1). Based on the literature [165, 177],
three compositions per each polymer is selected: 5%, 7%, and 9% (w/v) for MeAlg, and
5%, 10%, and 15% (w/v) for MeHA. Pluronic (F-127) was used as a sacrificial ink (40%
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(w/v)) [99]. The change in ink viscosity with shear rate for each formulation is shown in
Figure 2.2. Viscosity of the ink formulations significantly increased with increasing
polymer concentration for both MeAlg and MeHA. Shear thinning behavior (i.e., decrease
in viscosity with increasing shear) is observed for MeAlg formulations, 15% MeHA ink
and sacrificial ink. The viscosity values of MeAlg inks were significantly higher than that
of MeHA (except for 15% MeHA, which has a viscosity similar to 5% MeAlg), despite the
fact that MeHA inks had much higher polymer concentrations.
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Figure 2.2 Shear viscosity values with shear rate for MeAlg, MeHA, and Pluronic.

2.3.2 Line Tests Results for Matrix Hydrogel Inks
Line tests were performed on methacrylated glass slides to determine the optimal printing
parameters

(print

speed

and

pressure)

for

selected

needle-sizes

(0.21

and

0.30 mm in diameter). For instance, line test results for 9% MeAlg and 15% MeHA
showing the printed strut size (μm) with print speed (mm/s) for three different print
pressures (kPa) are given in Fig. 3. For MeHA inks, the strut size significantly increased
with increasing pressure for each print speed. For instance, strut size increased from 600
μm, for 138 kPa (20 psi), to 900 μm, for 207 kPa (30 psi), and to 1150 μm, for
276 kPa (40 psi). Strut size decreased with increasing speed. When struts printed at
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6 mm/s are compared with 10 mm/s, strut size decreased from 1150 to 900 μm, for
276 kPa; 900 to 700 μm, for 207 kPa; and 650 to 500 μm, for 138 kPa. For 9% MeAlg,
there was no significant change in strut size with pressure, but the strut size decreased
gradually with increasing speed. Line test results for all of the ink formulations are given
in Table 2.1.

Figure 2.3 Line test results for 15% MeHA (A) and 9% MeAlg (B) printed using a 0.21
mm diameter needle. 3D printed strut size (diameter) plotted against print-head speed for
extrusion pressures equal to 483, 552, and 621 kPa, for MeHA, and 138, 207, and 276 kPa,
for MeAlg.
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Table 2.1 Line Test Results Showing the Range of Printed Strut Size (diameter) with
Respect to Print Speed and Extrusion Pressure, and Corresponding Needle Size for Each
Formulation
Ink formulation
Needle size Print speed Pressure
Strut size
Hydrogel

% (w/v)

(mm)

(mm/s)

(psi)

(μm)

5

0.21

10-30

5-15

300-1400

5

0.30

10-30

5

800-1400

7

0.21

10-30

10-30

250-1100

7

0.30

10-30

5-15

350-1400

9

0.21

6-10

20-40

500-1100

9

0.30

10-30

10-20

500-1500

5

0.21

6-10

3-8

400-1000

5

0.30

NP*

-

-

10

0.21

6-10

10-30

400-700

10

0.30

6-10

5-15

300-1100

15

0.21

6-10

70-90

500-800

15

0.30

6-10

90

600-1300

MeAlg

MeHA

*: Not printable (NP)

2.3.3 Rheological Properties of the Printed Matrix Hydrogels
The evaluation of elastic modulus, viscous modulus, and phase angle was investigated
using time sweep tests for 9% MeAlg and 15% MeHA (Figure 2.4). Green boxes in the
figures show the light exposure periods, corresponding to partial crosslinking period (15
and 5 s for MeAlg and MeHA, respectively) and complete crosslinking period (240 and 90
s for MeAlg and MeHA, respectively). Our results showed that both formulations gelled
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during the partial crosslinking period, and gelation progressed further during the complete
crosslinking period.

Figure 2.4 Rheological characterization of matrix hydrogel inks 9% MeAlg (A and C) and
15% MeHA (A and D). Time-sweeps were performed to investigate the evolution of elastic
modulus (G’), viscous modulus (G”), and phase angle (Φ). Inks were tested for ~80 s,
followed by partial crosslinking (15 s for MeAlg and 5 s for MeHA) with UV light, and
fully crosslinking (240 for MeAlg and 90 s for MeHA), mimicking the channel printing
process. Green boxes show the light exposure region.

2.3.4 Line Tests Results for Sacrificial Hydrogel Ink
Line tests for sacrificial ink were done on methacrylated glass slides (Appendix A, Figure
A.2) and within matrix (MeAlg and MeHA) hydrogels (Figure 2.5). In general, strut size
increased with increasing needle size. For instance, when printed at 4 mm/s and 414 kPa
pressure, strut size was 85 μm for 0.08 mm needle, 300 μm for 0.10 mm needle, and 400
μm for 0.16 mm needle. Struts size increased with increasing pressure at a constant speed
and decreased with increasing speed at a constant pressure (Appendix A, Figure A.2).
Strut size was in the range of 85–380 μm, 200–800 μm, and 300–1200 μm for 0.08, 0.1,
and 0.16 mm needle size, respectively. Sacrificial ink was then printed within the matrix
hydrogels, and strut size was characterized before and after postprocessing to remove the
sacrificial hydrogel (to create channels). Figure 2.5 shows the data for MeAlg hydrogel.
Our results show that the strut size values were slightly higher within hydrogels as

29

compared to a glass slide (when printed at the same speed and pressure), but not
significantly different. There was no significant change in strut size before and after the
removal of the sacrificial ink. Note that struts (Figure 2.5B and D) became channels
(Figure 2.5C and E) after the removal of the sacrificial ink.

Figure 2.5 (A) Strut width (diameter), before (hydrogel strut) and after dissolution
(channel) of sacrificial hydrogel with matrix (MeAlg) hydrogel, is plotted against print
speed (mm/s) and pressure (psi). (B-C) Optical images of a representative strut before (B)
and after (C) dissolution. (D-E) Representative confocal 3D scans of a strut (D) and a
channel (E). In (D) rhodamine dye is mixed with Pluronic. In (E), the channel was injected
with a solution containing rhodamine dye, and dye diffused out of the channel. Scale bars
are 500 μm.

2.3.5 Controlling Channel Size with Print Speed
Print speed was used to control the printed sacrificial strut size, and hence, the channel size.
Figure 2.6 shows the picture of the MeAlg hydrogel device with two channels (injected
with red food coloring) with a gradient change in channel size. The channel at the top was
printed with 1 mm/s stepwise decrease in print speed from 10 mm/s to 1 mm/s, creating a
change in channel size from 250 μm to 1350 μm, followed by a 1 mm/s stepwise increase
in print speed to 8 mm/s. For each print (speed) step, the print length (strut length) was
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kept as 0.8 mm, except for the lowest speed, at which the print length was 1.6 mm. The
channel at the bottom (Figure 2.6) was printed by decreasing the print speed from 9 mm/s
to 1 mm/s at 1.8 mm print step size, forming a gradual increase in channel size from 400
to 500 μm to ~500 μm, and up to ~1300 μm. In these print studies, the print pressure was
kept constant at 621 kPa (90 psi), and 0.16 mm needle was used.

Figure 2.6 3D printed MeAlg hydrogel with two channels with varying channel sizes. (i)
and (ii) showing the print speed and channel size values plotted against print length,
corresponding to the channels in the top picture.
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2.3.6 3D Printing of Perfusable Channels Embedded within Hydrogels
3D digital designs and their corresponding printed constructs are shown in Figure 2.7.
Channels were injected with a red food coloring solution for visual clarity. In Figure 2.7A,
MeAlg hydrogel (10 × 10 mm) is shown with various channel sizes, including 732 ± 6 μm,
481 ± 46 μm, 423 ± 23 μm, and 367 ± 13 μm in diameter, from left to the right, respectively.
Figure 2.7B shows a 3D printed MeAlg hydrogel (10 × 10 mm) with linear channels (800
μm in diameter) on 2 different planes (in the z-direction), forming a checkerboard pattern.
Figure 2.7C shows 2D converged channels (800 – 1200 μm) embedded within a MeAlg
matrix (18 ×16 mm). In Figure 2.7D, MeHA hydrogel having wavy channels, in the form
of sine waves with constant wavelength (8 mm) but decreasing amplitude (2, 1, 0.5, and 0
mm), is shown. A connected closed-loop channel depicting ‘‘NJIT” letters within MeAlg
is shown in Figure 2.7E. In Figure 2.7F, two sets of linear channels (3 individual channels
per set, 500 μm in diameter) were printed at different x- and z-planes. Finally, a hydrogel
device with two reservoirs (6 mm in diameter) and connected with two embedded channels
(~800 μm in diameter) is shown in Figure 2.7G.
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Figure 2.7 Digital designs and corresponding 3D devices. (A) Linear channels with
different sizes in a MeAlg matrix (10 x 10 mm) (channel sizes from left to right: 732 ± 6
μm, 481 ± 46 μm, 423 ± 23 μm, 367 ± 13 μm). (B) MeAlg matrix (10 × 10 mm) with 2
layers of linear channels (800 μm in diameter). (C) MeAlg matrix (18 × 16 mm) with
converged channels (800-1200 μm). (D) Closed loop NJIT channel within MeHA hydrogel.
(E) Injecting red dye into complex channels; (E) Top and side view of a hydrogel (16 ×14
× 4 mm) with 2 sets of channels (500 μm in diameter) at different x- and z-plane; (F) 3D
printed wavy channels constant wavelength (8 mm) but increasing amplitude (2, 1, 0.5, and
0 mm). (G) Top and side view of a 3D printed device (30 × 20 mm) with 2 reservoirs (6
mm in diameter) connected with 2 channels (800 μm in diameter) embedded in MeAlg
hydrogel. All channels were injected with red food coloring.

2.3.7 Cell Culture within Channels
HUVECs were seeded and cultured up to 9 days within the channels. Figure 2.8 shows the
confocal scanning images of the HUVECs. Our results confirmed cell attachment and
complete (circumferential) coverage of the channels with HUVECs.
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Figure 2.8 Fluorescent images of the HUVECs cultured within channels (green showing
F-actin and blue showing nuclei). (A) Maximum projection image from top. Crosssectional (B) and top (C) view of the channels. Scale bars are 100 μm.

2.3.8 Bioprinting of Stem Cell-laden Hydrogels with Embedded Channels
hMSCs were used to investigate the effect of our channel printing approach on cell viability.
For this purpose, cells were mixed into our ink formulations (9% MeAlg and 15% MeHA),
and hydrogels with and without channels were printed following our protocol. Figure 2.9A
shows the representative confocal scanning images of the hMSCs (green indicates live cells,
and red indicates dead cells) after printing. Figure 2.9B and C show the percent (%) cell
viability up to 4-day culture. There was no significant change in the % cell viability
between groups for 1-day and 4-day culture. We observed a slight decrease in % cell
viability for cells cultured in MeHA without channels on Day 4. The cell viability was
around 89–90% for cells within MeAlg (both with or without channels) for culture Day 1
and 4, except for the without channels group at Day 4, which was slightly low (~86%). For
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the MeHA group, cell viability was 88% and 90% on Day 1, and 86% and 81% at Day 4,
with and without channels, respectively.

Figure 2.9 (A) Confocal scanning microscopy images of hMSCs (green indicating live
cells, and red indicating dead cells) bioprinted with MeHA and MeAlg hydrogels with and
without channels and cultured for 1 day. (B-C) Corresponding % viability data for hMSCs
cultured in MeHA (B) and in MeAlg (C) hydrogels for up to 4 days. *p<0.05, N.S.: not
significant.

2.4. Discussion
A novel bioprinting approach was developed to print user-defined and tunable
microchannels within photocurable hydrogels. Our approach enables the use of
commercially available photocurable hydrogels and sacrificial polymers/hydrogels without
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requiring any complex synthetic and processing procedures, desktop (dual-head)
bioprinters (e.g., Allevi-2), or any hardware modifications. In this study, we used
commercially available and commonly utilized MeAlg and MeHA hydrogels as the
photocurable matrix ink and Pluronic (F-127) as the sacrificial ink. MeAlg and MeHA
undergo radical polymerization in the presence of a photoinitiator when exposed to light,
forming a crosslinked network (or a hydrogel). The degree of crosslinking can be
controlled easily by controlling the methacrylate consumption, initiator concentration, and
light exposure time [174]. Methacrylates also undergo a Michael-type addition reaction
with thiols, thus allowing tethering of bioactive molecules containing cysteine groups [173,
174]. This could be useful to incorporate bioactive cues into the hydrogel matrix when
needed. For instance, we functionalized the matrix inks with RGD-peptide, following the
protocol developed previously [173, 174], to enhance stem cell-matrix adhesion
(Figure 2.9).
In this study, we first investigated the printability of the ink formulations by
performing single line (strut) tests on methacrylated glass slides. Methacrylation of the
glass slides was not required and did not affect the printing parameters or printed line size
but ensured strong adhesion of MeHA and MeAlg to the glass slide during line tests. For
matrix hydrogels, two different needles (0.21 and 0.30 mm in diameter) were used to
investigate the printability of these formulations. In addition to these two needles, we were
able to extrude the sacrificial hydrogel using a 0.08 mm needle due to its superior shear
thinning behavior as compared to matrix hydrogels (Figure 2.2). The main goal of these
studies was to adjust the print speed and pressure to obtain good quality struts (or lines),
i.e., continuous lines that are uniform in thickness without sagging or dragging. A wide
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range of print pressure (34–621 kPa) and speed (6 – 20 mm/s) were used to create lines
from 250 μm up to 1,500 μm in diameter (Table 2.1) for matrix hydrogels. As expected,
higher pressures were needed to extrude the more concentrated formulations. For instance,
a print pressure in the range of 483– 621 kPa was needed to extrude 15% MeHA, whereas
the pressure was in the range of 138–276 kPa for 9% MeAlg (Figure 2.3). Note that the
initial viscosity values for the MeAlg formulations were much higher than that of MeHA,
but MeAlg formulations showed a higher degree of shear-thinning (Figure 2.2). We
believe that this allowed the 9% MeAlg to be printed at lower pressures. We usually
observed an increase in strut size with increasing pressure (as more material is extruded)
at a constant speed and a decrease in strut size with increasing speed at a constant pressure.
As shown in the results section (Figure 2.3), this was more pronounced in 9% MeAlg as
compared to 15% MeHA (Figure 2.3). We believe that this is mainly due to the
significantly higher print pressures for MeHA. As our printing approach requires partial
crosslinking immediately after printing, we decided to use the formulations with the highest
polymer concentrations (15% MeHA and 9% MeAlg) to reduce the partial crosslinking
time, to allow sufficient support to the sacrificial hydrogel when the matrix hydrogel is in
its uncrosslinked state, and to limit mixing between the matrix hydrogel and the support
hydrogel. Thus, to form the matrix layers, 9% MeAlg was printed at a pressure of 138 kPa
and a print speed of 10 mm/s, using 0.21 mm diameter needle. 15% MeHA was printed at
a pressure of 552 kPa and a print speed of 10 mm/s, using the same needle. These
conditions corresponded to ~500 μm diameter line (Figure 2.3) and led to printed layers
that are ~500 μm in thickness. When needed, the matrix layer height was increased by
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lowering the print speed (or increasing the pressure) to allow printing of larger size (>500
μm) sacrificial lines within the matrix layer.
For Pluronic (sacrificial ink), line test studies were crucial as the strut size directly
determined the channel size (Figure 2.5). Line tests were first performed on the glass slides,
to determine the relationship between print parameters and strut size. The strut sizes could
be printed as low as 85 μm using a 0.08 mm needle. The next step was to use these
parameters to print Pluronic in the matrix hydrogel. For this purpose, we first confirmed
that the needle moved freely within the selected matrix formulations (15% MeHA as
compared to 9% MeAlg) and that Pluronic did not mix with the selected matrix
formulations when printed within. Note that it is not possible to use the free-form printing
approach (discussed in the introduction) here, as formulations with much higher polymer
concentrations are needed to support Pluronic when a support bath (filled with matrix
formulation) is used, which would hinder the needle motion. Our approach overcomes this
issue by taking advantage of a sequential crosslinking approach, completely eliminating
the need for a bath of support material.
In our approach (Figure 2.1), we printed the (photocurable) matrix ink layer-bylayer as usual. To create self-supporting layers, each layer was briefly exposed to light (5
s for MeHA, 15 s for MeAlg) to partially photocrosslink the layer. The ink formulations
behaved like a viscous liquid (indicated by G’’ > G’) (Figure 2.4). When partially
crosslinked, both G’ and G’’ increased, but G’ became larger than G’’, indicating a
transition from a viscous behavior to an elastic behavior (gel point defined at G’ = G’’). At
this stage, printed hydrogel layer was able to self-support itself. After the second layer of
matrix material was printed, Pluronic was directly printed inside the top layer, and then the
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layer was exposed to light for partial crosslinking. A final layer of matrix material was
printed, followed by partial crosslinking. The construct was then exposed to light to fully
crosslink the construct (240 s for 9% MeAlg and 90 s for 15% MeHA). At this stage, we
observed a significant increase in G’ and a significant decrease in phase angle, confirming
the complete gelation. The line test results showed that Pluronic strut size was slightly
larger but not significantly different when printed inside the matrix hydrogel as compared
to struts printed on the glass slides (at the same print pressure and speed). Struts were
dissolved in DPBS within minutes to form channels, and there was no significant difference
between the strut and channel size (Figure 2.5). This was due to the equilibrium swelling
behavior of the matrix hydrogels in their fully crosslinked state, which limited the volume
changes caused by swelling. One of the advantages of our approach is the ability to control
the channel size by simply controlling the print speed. This allowed fabrication of
individual channels with varying sizes, or a channel with varying size (Figure 2.6), without
changing the print needle.
To show the applicability of our approach, we developed a wide range of hydrogel
devices with embedded channels, with different sizes, shapes, and complexity (Figure 2.7).
We were also able to print a commonly used microchip design from MeAlg hydrogel. The
size of these devices was not limited by the printing step but the ability to keep the devices
in a humid environment. Larger devices tend to shrink with time, which is a gradual process
and usually starts from the top surface, leading to slight deformations in the hydrogel
(Figure 2.7G). This is typical behavior for hydrogels, and it could potentially be eliminated
by keeping the hydrogels in a humidity-controlled chamber or in an aqueous media
immediately after the printing process.
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Finally, we successfully showed the compatibility of our printed devices for cell
culture by performing two separate in vitro studies using HUVECs and hMSCs. These cell
types are significant and commonly used models: hMSCs are used for tissue regeneration,
and organ printing due to their ability to migrate, proliferate, and differentiate into many
tissue types (muscle, cartilage, and bone) and HUVECs are important in understanding
vascularization and angiogenesis. HUVECs were seeded inside the channels and cultured
for 9 days to investigate cell adhesion and monolayer formation. Our results showed that
cells attached inside the channels circumferentially and formed confluent layers. Note that
cells that did not attach to the channels formed large aggregates and eventually died in the
absence of adhesive peptides. Our future goal is to further investigate the endothelization
and permeability of the endothelial layer. In a separate study, hMSCs were incorporated
into the ink formulations to test the cell viability. The goal was to check if our printing
approach had an effect on cell viability. Cell viability was 90% after 1 day of culture and
slightly dropped (but not significantly) after 4 days of culture. But for MeAlg and MeHA
without channels, this drop was about 5% and 10%, which is not surprising considering
these were bulk hydrogels. The presence of channels enhanced viability as expected.
Overall, these results show the feasibility of our approach to fabricate 3D printed cell
culture platforms.

2.5. Conclusions
In conclusion, a novel approach was developed to 3D print complex microchannels within
photocurable hydrogels. Specifically, photocurable hydrogels were used as bioinks to print
constructs layer-by-layer and exposing each printed layer to light ensured the formation of
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self-supporting layers. This approach enabled direct printing of a sacrificial hydrogel into
a freshly printed photocurable hydrogel layer. This freshly printed hydrogel layer confined
and supported the sacrificial strut. After complete crosslinking of the hydrogel layer, the
sacrificial hydrogel was washed away to form channels. Endothelial cells adhered and
formed confluent layers within these channels. When incorporated into the photocurable
ink formulations, stem cells remained highly viable within the matrix hydrogels.
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CHAPTER 3
NOVEL BIOINKS FROM UV-RESPONSIVE NORBORNENEFUNCTIONALIZED CARBOXYMETHYL CELLULOSE MACROMERS
This chapter has been adapted from the publication:
S. Ji, A. Abaci, T. Morrison, W.M. Gramlich, M. Guvendiren, Novel bioinks from UVresponsive norbornene-functionalized carboxymethyl cellulose macromers, Bioprinting 18
(2020) e00083.

3.1 Introduction
Three dimensional bioprinting is an emerging field with a significant potential to create
custom-designed and patient-specific “living” constructs using a patient’s own medical
images and cells [9, 27, 28, 178]. 3D bioprinting could potentially eliminate organ shortage
[59, 82, 142, 146] and enable development of patient-specific tissue models for
personalized drug screening [145, 150, 179-181]. A recent frontier is in situ bioprinting for
reparative or regenerative therapy, in which a living tissue is printed directly at the site of
an injury or a defect [182-184]. Despite the strong potential of bioprinting and recent
advancements in the bioprinting technology, there is a notable lack of diversity in bioinks
which significantly hinders the widespread use of bioprinting.
Three dimensional bioprinting enables layer-by-layer manufacturing of a living
construct from bioinks, which are bioprintable formulations composed of cells that are
usually supported with a hydrogel [89]. The requirement for live cell printing significantly
limits the number of additive manufacturing technologies that are suitable for bioprinting
[185]. Bioprinting technologies include extrusion-based direct ink writing (DIW), dropletbased inkjet printing, and light-based approaches, including projection stereolithography
and laser-induced forward transfer (LIFT) [10, 20, 185]. DIW is the most commonly used
technique due to its availability, affordability, and ease of use. In DIW, a bioink
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formulation is extruded through a blunt needle to form a self-supporting structure. In this
process, the bioink should meet the basic requirements for extrusion-based bioprinting
[186-188], such that it should (i) have a suitable viscosity, i.e., low enough for easy
extrusion yet high enough for formation of self-supporting layers post-printing to minimize
sagging, usually in the range of 30 to 6 × 107 mPa·s, and (ii) allow printing of living cells
and support high viability (>90%) [89, 186, 187]. In addition, the bioink and its degradation
products should be cytocompatible and should not induce an inflammatory response when
implanted [187, 189].
Most commonly used bioinks are formulated from cell-laden hydrogels due to their
high-water content and properties mimicking native tissue microenvironment [44, 45]. A
variety of hydrogel-based bioinks have been developed from synthetic (such as Pluronic
[190, 191] and poly(ethylene glycol) [192]), or natural (gelatin [193-195], hyaluronic acid
[130, 196], alginate [196, 197], chitosan [198], collagen [199, 200], fibrin [201], and silk
[202, 203]) polymers/macromers , or decellularized tissue materials (e.g., heart, bone, liver,
pancreas, etc.) [204, 205]. The building blocks of these formulations are usually modified
to allow tunable viscosity and shape fidelity during printing process. Although innovative
approaches have been developed to control printability including pre-crosslinking to
control flow [192] or rapid crosslinking during or after-printing [206, 207], or designing
shear thinning formulations [130, 208], novel bioink formulations are still needed to
broaden the currently available bioink “library” and to develop stimuli responsive bioinks
enabling control of bioprinted construct properties post-printing.
This study is focused on carboxymethyl cellulose (CMC), a commonly used
cellulose derivative. Cellulose is one of the most abundant and renewable natural polymers

43

[209, 210]. As a natural polymer, cellulose is inherently bioactive, biodegradable, and
biocompatible [209]. The hydroxyl groups on its backbone structure allows
functionalization of cellulose to tune its properties [211]. When compared to cellulose,
CMC is highly soluble in water due to its carboxyl groups [212] making it an attractive
building block for hydrogels. CMC-based hydrogels have been developed utilizing a wide
range of crosslink mechanisms including physical and chemical crosslinking [13]. For
instance, Nie et al. reported CMC-based hydrogels by crosslinking sodium CMC with
AlCl3, and studied the effects of crosslinker, CMC concentration and temperature on
hydrogel stiffness and degradation [16]. Chemically crosslinked CMC-based hydrogels
have been developed using irradiation-initiated [17-19], photo-initiated radical [20, 21],
enzymatic [22], and epoxide-opening reactions [23]. For instance, methacrylated CMC is
synthesized to allow photo-initiated radical reaction to fabricate CMC-based hydrogels.
These hydrogels were used to facilitate chondrogenic differentiation of encapsulated
human mesenchymal stem cells (hMSCs) encapsulated within the hydrogels [21].
Cellulose has been used a filler, or as a component, in ink formulations [213-216].
Majority of the studies utilized cellulose/alginate-based ink formulations, utilizing a range
of cellulose derivatives (nanofibrillated cellulose, nanocellulose, and methylcellulose) and
taking advantage of physically crosslinking ability of alginate with CaCl2 [217-222]. For
instance, nanocellulose-alginate based bioinks were developed for 3D bioprinting of
human chondrocyte-laden hydrogels for cartilage regeneration [217, 223]. Muller et al.
developed alginate sulfate/nanocellulose bioinks but reported significantly compromised
proliferation ability of chondrocytes during printing process [220]. Markstedt et al.
developed bioinks from cellulose nanofibrils mixed with xylan for crosslinking [224]. Most
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recently, methylcellulose (MC)-based hydrogels were printed utilizing the sol-gel
transition, or lower critical solution temperature (LCST), allowing printing of MC-based
hydrogels at 21℃ with high cell survival (80%) post-printing [225]. Li et al. developed
highly thixotropic inks from alginate/methylcellulose blend hydrogels, and showed that the
treatment of the printed constructs with trisodium citrate (TSC) significantly enhanced the
interfacial bonding between printed layers [226]. Finally, Lewis group developed hydrogel
composite inks composed of soft acrylamide matrix supported with cellulose fibrils, and
crosslinked with clay [213]. They were able to selectively align cellulose nanofibrils during
the printing process to develop 3D printed structures with anisotropic stiffness, which led
to shape change on immersion in water. In this study, novel photocurable bioink
formulations were developed directly from carboxymethyl cellulose (CMC) eliminating
the need for alginate or other additives/components.
Light-induced free radical polymerization of methacrylates or acrylates is a widely
used approach in designing photoreactive bioinks, yet this reaction is not specific and leads
to formation of a heterogenous network composed of kinetic chains. Thiol-norbornene
photo-click chemistry is specific to norbornene and thiyl radicals (i.e., radicals from thiols)
as compared to norbornene radicals (its own radicals) or nonradical thiols [227, 228]. This
is important to achieve selectivity in crosslinking (crosslinkers containing multi-thiols) and
tethering of biomolecules (containing mono-thiols). This mechanism ensures a more
homogeneous crosslinking in a controllable manner [227, 229, 230]. Natural (such as
alginate [231], hyaluronic acid [230, 232], and gelatin [233, 234] and synthetic polymers
(such as poly(ethylene glycol) [229, 234, 235]) have been modified with norbornene group
to fabricate photocurable, cell-laden hydrogels. Recently, CMC has been modified with
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norbornene groups [212, 236] to develop renewable hydrogels. Gramlich group recently
demonstrated high cell viability of encapsulated stem cells within norbornene
functionalized CMC [237]. Motivated by these recent results, we focused on developing
novel bioink formulations from norbornene functionalized CMC.
In this study, we report two novel stimuli responsive bioink platforms from CMC
for extrusion based bioprinting. CMC is functionalized with thiol-ene reactive norbornene
(Nor) with an amide, norbornene CMC (NorCMC), or an ester linker, carbic (norbornene)
functionalized CMC (cCMC). CMC was chosen as the building block for both of our bioink
platforms due to its high availability and low cost, and high solubility in water. Lightinduced thiol-ene click chemistry enabling norbornene was selected as the functional group
to achieve selective crosslinking and selective tethering of biomolecules. Printability of the
bioink platforms was determined by the thiol-Nor ratio for each macromer concentration.
CMC-based bioink platform allows tunable printability, stiffness, and high viability of
bioprinted cells, and broadens the range of currently available bioink platforms.

3.2 Material and Methods
3.2.1 Polymer Synthesis
The macromers, cCMC and NorCMC, were synthesized according to methods developed
previously for cCMC [236] and NorCMC [237]. To synthesize cCMC, CMC (90 kDa, 0.7
carboxymethyl groups per anhydroglucose unit, Sigma) was dissolved in reverse osmosis
(RO) water at 1% (w/v). Then, 7.26 g of cis-endo-5-norbornene-2,3-dicarboxylic
anhydride (carbic anhydride, TCI) was added to the CMC solution (per gram of CMC).
The reaction was maintained for 2 hours while the pH of the reaction was adjusted at the
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range of 9.0-10.5 by dropwise adding 10M NaOH. Subsequently, 10-fold volume of the
reaction solution of ice-cold acetone was used to precipitate the reaction solution. The
precipitate was collected by suction filtration and dissolved in RO water at 1% (w/v) and
dialyzed (6-8 kDa) against RO water for 3 days followed by lyophilization. For NorCMC,
sodium CMC (90 kDa, Sigma) was dissolved in RO water at 1% (w/v), and 0.592 g of 1ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC HCl), 0.356 g of Nhydroxysuccinamide (NHS), and 0.4 mL of 5-norbornene- 2-ethylamine (NA) were added
(per gram of sodium CMC). The reaction solution was stirred and maintained at room
temperature for 18 hours. NaCl was added to the reaction solution, stirred at room
temperature for 30 min, and the reaction solution was precipitated in 10-fold ice-cold
acetone. The precipitate was dissolved in RO water at 1% (w/v) and dialyzed (6-8 kDa)
against RO water for 3 days followed by lyophilization. The extent of the modification for
both polymers was characterized using 1H NMR spectroscopy using a Bruker Avance Neo
500 MHz spectrometer (NorCMC) and a Varian Inova 400 MHz spectrometer (cCMC).
3.2.2 Cell Culture and Maintenance
Human mesenchymal stem cells (hMSCs, passage 4, Lonza) were cultured in the growth
media (MEM-α (Gibco), supplemented with 10% fetal bovine serum (FBS, Gibco) and 1%
penicillin-streptomycin (pen-strep, Gibco)) at 37 ℃ and 5% CO2. Growth media was
refreshed every 3 days. Human umbilical vein endothelial cells (HUVECs, passage 5,
Lonza) were cultured in EGM-2 media (EGM-2 Bullet Kit, Lonza). Media was changed
every two days to ensure a proper cell proliferation. NIH 3T3 fibroblasts were cultured in
DMEM (Gibco) supplemented with 10% FBS (Gibco) and 1% pen-strep (Gibco). Media
was refreshed every 3 days.
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3.2.3 Ink Preparation
Ink formulations contained norbornene modified CMC (15% (w/v) for cCMC and 10%
(w/v) for NorCMC) and 0.05% (w/v) lithium phenyl-2,4,6-trimethylbenzoylphosphinate
(LAP, Allevi) in growth media. For instance, to prepare a 10% NorCMC, 100 mg of
NorCMC was dissolved in 1 ml of 0.05% LAP stock solution in growth media in a glass
vial, covered with an aluminum foil. The solution was stirred overnight at room
temperature. To adjust the pH of the cCMC solution to pH = 7.5, 20 μL of triethylamine
(Sigma Aldrich) was added to the cCMC solution.
To prepare a bioink, 900 μL of LAP stock solution was used to dissolve the polymer.
Then, the solution was mixed with 100 μL of cell suspension (hMSC, 3T3, or HUVEC;
1×107 cells/mL) using a magnetic stirrer, leading to a final ink concentration of 15% cCMC
(or 10% NorCMC). Each ink formulation was transferred into a BD Luer-Lok™ 10-mL
syringe prior to printing. Prior to printing process, pre-calculated amount of the crosslinker
(DL-dithiothreitol (DTT), Sigma) was added to the bioink formulation and stirred gently
for 1 minute.
3.2.4 Rheological Characterization of the Ink Formulations
Malvern Ultra+ Rheometer (flat plate geometry, 20 mm, 1 mm gap) was used to analyze
the rheological properties of the ink formulations. To investigate the crosslinking process
in the absence of light exposure, time sweep tests were performed at a frequency of 1 Hz
and an oscillatory strain of 0.05%. Elastic modulus (G’), viscous modulus (G’’), viscosity
(γ) and phase angle (Φ) values were recorded. To investigate the photocrosslinking process,
inks were casted on to the lower plate of the rheometer, and time sweep tests were
performed using an optical kit (Malvern) connected to a UV light source (Omnicure S2000,
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356 nm, 5 mW/cm2). Light intensity was adjusted to represent the intensity during printing
process (405 nm, 40 mW/cm2) according to the molar absorptivity spectrum of the
photoinitiator (LAP) [175]. The UV light was turned on for 4 minutes after 1 minute of
equilibrium time during time sweep tests. Initial viscosity values refer to mean of the
viscosity values measured for the first 1 min prior to UV exposure.
3.2.5 Mechanical Properties of the Crosslinked Ink Formulations
Malvern Ultra+ Rheometer (flat plate geometry, 8 mm) was used to measure the
compressive modulus (Young’s modulus, E) of the samples. Two sets of disc-shaped
hydrogel samples (1 mm in thickness and ~25 mm in diameter) were prepared via direct
casting followed by UV exposure and bioprinting process. Samples were kept in DPBS for
24 hours to ensure equilibrium swelling. The compression test was performed by applying
a compressive normal force to the hydrogel sample using the upper flat plate geometry
while monitoring the gap distance (where strain is equal to the gap - sample thickness). To
ensure initial contact, an initial compressive force equal to 0.05 N was applied. The
compressive force was increased continuously (0.1 mm/s) up to 2 N. The compressive
modulus (E) was obtained by calculating the slope of stress-strain curve (using the linear
range within 10% strain).
3.2.6 Scaffold Design
3D scaffold designs were created by Autodesk® Fusion 360™ and the 3D models were
sliced with Slic3r in Repetier-Host to generate G-code files. A 15mm × 15 mm grid-like
2-layer scaffold and a 12 mm × 8 mm 3-layer cuboid were designed for printability tests
and cell viability tests.
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3.2.7 Line Test
Ink formulations were used to print individual struts (lines) on a glass slide at different
print pressures and speeds. The images of the printed struts were captured by a microscope.
Three random parts of each strut (from three samples per each group) were captured for
analysis. The strut diameter was measured using ImageJ). 10% Methacrylated hyaluronic
acid (MeHA) was used as a control group.
3.2.8 Printability Test
In this study, an Allevi 2 (Allevi) bioprinter was used to perform all the printing processes.
After mixing with DTT, the bioink formulations were immediately transferred to a 10-mL
syringe, and the syringe was mounted on the printer. To test the printability, the bioink was
used to print a 15 mm × 15 mm grid-like 2-layer scaffold on a methacrylated glass slide
(following the surface treatment protocol described previously [176]). The elapsed time
was also recorded after mixing DTT in bioink formulation. Printing parameters were
optimized with respect to this elapsed time to print uniform grids. Methacrylated
hyaluronic acid (MeHA) was used as a control group. To print thick hydrogel scaffolds (>
3 mm), 30% Pluronic F-127 was used as a support ink. After crosslinking process, the
scaffolds were immersed in DPBS at 4 oC to remove Pluronic support. To print multimaterial scaffolds, cCMC 1:4 and NorCMC 1:2 were prepared as mentioned. To
distinguish different inks, 100 μL of food color was added to cCMC 1:4.
3.2.9 3D Bioprinting of Cell-laden Hydrogels
Cell-laden bioink (15% cCMC or 10% NorCMC) was printed on methacrylated glass slides
at optimized parameters obtained from printability tests. The printed cell-laden scaffolds
were immediately transferred into non-treated 6-well plates and 5 mL of growth media was
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added into each well. Methacrylated hyaluronic acid (MeHA) was used as a control group.
3.2.10 Cell Viability Tests
Cell-laden hydrogels were cultured for 7 days, and live-dead staining was performed at
Day 1, 4, and 7 to characterize the viability of the encapsulated cells. Cell-laden hydrogels
were washed with DPBS and then stained with calcein-AM (“live”, 0.5 μL/mL) and
ethidium homodimer (“dead”, 2 μL/mL) for 15 minutes. Samples were washed with DPBS
and transferred to confocal laser scanning microscope (confocal and 2-photon scanning
microscope, Leica) to capture fluorescent images of the cells. Two samples per group was
prepared for each time points and 3 random regions of the gel were scanned. The viability
was calculated by counting cells using ImageJ.
3.2.11 Statistical Methods
If not stated specifically we used three samples per each group for all studies. The data
were analyzed using KaleidaGraph. Data are presented as mean ± standard deviation.
ANOVA with Tukeys HSD post hoc test of means was used to make comparisons between
sample groups.

3.3 Results
3.3.1 Bioink Formulations
In this study, two distinct bioink formulations were developed from norbornene
functionalized CMC (Figure 3.1), either with an amide, NorCMC, or an ester linker,
cCMC. 1H NMR results confirmed 30% and 20% functionalization for cCMC and
NorCMC, respectively (Appendix B, Figure B.1). The compositions of the bioink
formulations are given in Table 3.1. Bioinks were formulated at 15% cCMC and 10%
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NorCMC, with thiol to norbornene ratio (T:NB) equal to (1:4), (1:2), and (1:1).

Figure 3.1 Chemical structure, modification reaction, and crosslink mechanism of (A)
NorCMC and (B) cCMC.

Table 3.1 Composition, Corresponding Viscosities, and Autogelation Time of Tested Ink
Formulations
Ink formulation
Polymer
(T:NB)
Initial viscosity
Gelation time
concentration
(Pa•s)
(min)
cCMC (1:4)

15%

(1:4)

0.8±0.10

91

cCMC (1:2)

15%

(1:2)

1.2±0.10

57

cCMC (1:1)

15%

(1:1)

1.5±0.03

29

NorCMC (1:4)

10%

(1:4)

0.8±0.09

>180

NorCMC (1:2)

10%

(1:2)

1.2±0.09
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NorCMC (1:1)

10%

(1:1)

2.8±0.03

26

52

3.3.2 Rheological Test Results
The initial shear viscosities of the bioink formulations were in the range of 0.8-2.8 Pa•s
(Table 3.1). The gelation behavior of the formulations was characterized with time sweep
experiments, in which the elastic modulus (G’), viscous modulus (G’’), and phase angle
(Φ) values were recorded (Figure 3.2). For all of the formulations, autogelation behavior
is observed within 3 hours in the absence of UV light. The gel point, i.e., onset of gelation,
and the elapsed time for equilibrium for each formulation are summarized in Table 3.1.
The gel point decreased with increasing T:NB, or increasing crosslinker concentration. For
cCMC, gelation time significantly increased from 29 min (1:1) to 91 min (1:4). For
NorCMC, gelation time values were 26, 40, and greater than 180 min, for (1:1), (1:2), and
(1:4), respectively.

A

B

C

D

E

F

Figure 3.2 Time sweep test of ink formulations without light exposure. (A-C) 10%
NorCMC with thiol to norbornene ratio, (T:NB) equal to (1:4) (A), (1:2) (B), and 1:1 (C).
(D-F) 15% cCMC with (T:NB) = 1:4 (D), 1:2 (E), and 1:1 (F).

To investigate the gelation under light exposure, samples were exposed to UV light
during time sweep tests (Figure 3.3, and Appendix B, Figure B.2). For cCMC,
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independent from T:NB, gel point was equal to ~18 s, and it took approximately 120 s for
crosslinking reaction to reach equilibrium. For NorCMC, the gelation time and equilibrium
time were equal to ~5 s and ~60 s, respectively. The magnitude of the equilibrium shear
modulus (G’) was determined by the composition of the ink formulation, such that a higher
(T:NB) resulted in a higher G’. For cCMC formulations, the equilibrium values for G’ were
equal to ~3200 Pa for (1:4) and ~9300 Pa for (1:2). For NorCMC, the equilibrium values
for G’ were equal to ~4600 Pa for (1:4) and ~8700 Pa for (1:2).

A

B
UV

UV

Figure 3.3 Time sweep test of ink formulations under light exposure for: (A) NorCMC
(1:4) and (B) cCMC (1:4). Green area denotes the UV exposure period.

3.3.3 Mechanical Tests Results
To probe the mechanical properties, the compression moduli were measured using 3D
printed samples from all of the ink formulations. As shown in Figure 3.4A, for the same
macromers, higher (T:NB) resulted in higher compressive moduli. For 15% cCMC, the
compressive modulus increased by ~7-fold (from 46 to 316 kPa) when the (T:NB)
increased from (1:4) to (1:2). The same trend was observed for 10% NorCMC, but the
increment was less than 3.3-fold (from 40 to 133 kPa).
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3.3.4 Swelling Tests Results
Swelling tests were conducted on 3D printed samples (Figure 3.4B). Our results showed
that increasing (T:NB) resulted in a 1.8 fold decrease in the swelling ratio (from 26 to 14
kPa) for cCMC, and a 1.6 fold decrease in the swelling ratio (from 24 to 15 kPa) for
NorCMC.

Figure 3.4 (A) Compressive modulus (E) values of the 3D printed hydrogels from bioink
formulations. p<0.005 for cCMC (1:2), as compared to the rest of the sample groups, and
for NorCMC (1:2), as compared to the other groups. (B) The equilibrium swelling ratios
values of the 3D printed hydrogels. p<0.005 for cCMC (1:4) and for NorCMC (1:2), as
compared to cCMC (1:2) and NorCMC (1:2).

3.3.5 Line Test Results
Figure 3.5 shows the line test results for 15% cCMC and 10% NorCMC. MeHA (10%)
was used as a control group. In general, strut size increased with increasing print pressure
and decreasing print speed. For instance, at 10 mm/s, the line width increased from 920 to
1390

m for cCMC, from 850 to 1790

m for NorCMC, and from 1110 to 1720 μm for

MeHA, when the pressure was increased from 138 kPa (20 psi) to 276 kPa (40 psi). When
printed at 20 mm/s and 138 kPa print pressure, it was possible to achieve 630 μm for cCMC,
620 μm for cCMC, and 800 μm for MeHA.
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Figure 3.5 (A) Line test results for 15% cCMC, 10% NorCMC and 10% MeHA bioinks.
Error bars denote standard deviation for n ≥ 5. (B) Printability tests for 15% cCMC and
10% NorCMC for different (T:NB). The x-axis shows the elapsed time after mixing the
crosslinker (DTT) with the ink formulation. Printability test result for 10% MeHA is given
as a control.

3.3.6 Printability Test Results
Ink formulations from cCMC and NorCMC (both formulations with (T:NB) equal to (1:4)
and (1:2)), were used to print grid-like scaffolds (Figure 3.5) to investigate printability.
The pressure was set at 138 kPa (20 psi) at the beginning (for 30 min delay time) and
gradually increased to 276 kPa (40 psi, for 60 min delay time) and 345 kPa for (50 psi, for
90 min delay time) to compensate the increment of the ink viscosity due to autogelation.
The print speed was controlled between 5 mm/s and 10 mm/s to print the gel with a uniform
shape. Due to autogelation, ink formulations were not extrudable after a certain time for
each formulation that was marked with a cross sign in Figure 3.5. Dual material printing
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was used to bioprint thick hydrogel scaffolds (NorCMC (1:2)) supported with sacrificial
Pluronic, and NorCMC (1:2) scaffolds with fast degrading cCMC (1:4) patterns (Figure
3.6).

Figure 3.6 Pictures showing multi-material printing of thick (>3 mm in height) scaffolds.
(A-B) Top (A) and side (B) views of NorCMC (1:2) scaffold printed with Pluronic (red).
(C-D) Scaffold after Pluronic is dissolved in DPBS. (E-F) NorCMC (1:2) scaffolds printed
with fast degrading cCMC (1:4) (red). Scale bars are 5 mm.

3.3.7 Bioprinting Test Results
Figure 3.7A shows the cell viability data (in percentage) for hMSCs, 3T3 cells, and
HUVECs. Note that cCMC sample group degraded in the medium after Day 4.
Figure 3.7B shows the confocal images of the stained cells, in which the green indicates
live cells, and the red indicates dead cells. In the side view images, the range of cells in the
vertical direction was different due to the different swelling properties for each ink
formulation.
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Figure 3.7 (A) Plots showing % cell viability with culture time for cells (hMSCs, NIH 3T3
cells and HUVECs) cultured within bioprinted cCMC, NorCMC and MeHA hydrogels.
* indicates the cCMC (1:4) sample group that degraded before Day 7. (B) Confocal
fluorescent images of cells (hMSCs, NIH 3T3 cells and HUVECs) within bioprinted cCMC,
NorCMC and MeHA hydrogels (green indicating live cells and red indicating dead cells).
(Scale bars are 200 μm) For hMSC, αp < 0.005 cell viability for MeHA at Day 1 vs. at
Day 4 and at Day 7, and at Day 4 vs. at Day 7; cell viability for cCMC (1:4) as compared
to NorCMC (1:4) at Day 1; cell viability for NorCMC (1:2) as compared to MeHA at Day
7; βp < 0.0001 NorCMC (1:4) vs. MeHA at Day 7. For NIH 3T3 cell line, αp < 0.005 cell
viability for MeHA at Day 1 vs. Day 4 and Day 7; cell viability of MeHA as compared to
NorCMC (1:2) and (1:4) at Day 1 and at Day 7; γp <0.005 for NorCMC at Day 1 vs. Day
7. For HUVECs, αp < 0.005 cell viability for NorCMC (1:4) and (1:2) at Day 1 vs. Day 7;
cell viability for MeHA as compared to NorCMC (1:2) and (1:4) at Day 1. For all groups
n=6.

3.4 Discussion
Here, we report novel bioink formulations from norbornene modified, cellulose-based
macromers for the first time. Cellulose-based materials are promising candidates as bioinks
due to their inherent bioactivity, abundance, and low cost. In this study, two distinct
macromers were developed by functionalizing CMC with an amide (NorCMC) or an ester
linker (cCMC) with 30% and 20% functionalization for cCMC and NorCMC, respectively.
These degrees of functionalization were selected because hydrogels at the same thiol to
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norbornene ratio and low solids content (4 wt% polymer) yielded similar compression
modulus values [74,75]. Our previous studies (utilizing the same extrusion-based printer)
revealed that an initial viscosity in a range of 1-10 Pa•s was ideal for a non-shear-thinning
hydrogel when a 27-gauge needle was used [196]. To adjust the viscosity of the inks within
this range, polymer concentrations were set to 15% for cCMC and 10% for NorCMC, due
to differences in solubilities of the macromers. A higher concentration of cCMC was used
as compared to NorCMC to yield similar bioink initial viscosities. The cCMC polymer is
significantly easier to dissolve than NorCMC because additional carboxylic acid groups
are introduced through the functionalization reaction (Figure 3.1). This behavior translated
into similar bioink viscosities at different polymer concentrations. Additionally, since the
norbornenes are connected to the CMC with different functional groups, degradation
behavior was expected to be different with the ester linkages of cCMC degrading earlier
than the amides of NorCMC.
Crosslinker, or thiol, to norbornene ratio (T:NB) was systematically increased,
from (1:4), (1:2) and to (1:1), to investigate the effect of (T:NB) on bioink properties. For
cCMC, the viscosity values did not change significantly with (T:NB). However, for
NorCMC, we observe a significant increase in viscosity with increasing (T:NB), such that
a 2-fold increase in viscosity is observed when (T:NB) increased from (1:4) (0.8 Pa•s) to
(1:1) (2.8 Pa•s). This we believe is due to the spontaneous crosslink of the macromers in
the absence of UV light, i.e., autogelation process. Rheological evaluation of the
formulations revealed autogelation in all formulations, but the gel point (onset of gelation)
decreased significantly with increasing (T:NB). The mechanism of this phenomena has not
been understood yet, but it is previously reported that the autogelation accelerates with
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increasing thiol and norbornene concentrations, increasing temperature, dissolved oxygen,
and acidic conditions [212]. Previous chemical characterization of the autogelation has
indicated that it is still a thiol-norbornene reaction, which must be initiated through radicals
spontaneously produced in the solution [50]. Future work aims to understand the origin of
these radicals. Note that cCMC is acidic when directly dissolved in the growth media or
DPBS (pH reaching to ~4) due to the presence of carboxylic acid units in the carbic groups.
Therefore, we adjusted the pH to 7.6 (as described in the experimental section) to mainly
eliminate cell viability issues. We found that cCMC could form a gel within few minutes
when the pH is not adjusted (Appendix B, Figure B.3). Considering the autogelation
behavior of our macromers, the gelation time (gel point) is considered as a critical
parameter for planning the printing process, since these hydrogels were not extrudable
when gelled. Considering the time required for pre-printing process, we decided to
eliminate the macromer formulations with gel point below 1 hour (Table 3.1 and
Figure 3.5). Thus, macromer formulations with highest (T:NB), (1:1), for both macromers
were eliminated.
Norbornene groups allowed the macromers to be photoresponsive which can lead
to crosslinking in the presence of a photoinitiator (LAP) and a crosslinker (DTT) when
exposed to light. Rheological tests in the presence of a UV light source allowed us to
determine the photocrosslinking parameters to be used during the bioprinting process. For
cCMC, it required ~18 s to gel and ~120 s to completely crosslink, which directed us to set
the partial crosslink time to be 30 s and the post-print crosslinking time to be 120 s
(Figure 3.3). The crosslink setting for NorCMC was also set as 10 s for partial crosslinking
and 90 s for post-print crosslinking. The printability tests were conducted to evaluate the
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printability and to optimize the print parameters (print speed, print pressure, layer height,
blue light exposure time). In the printing phase, some deviations between the rheological
data (Figure 3.2) and printing results (Figure 3.5) were observed. In Figure 3.2E, the
gelation time of cCMC 1:2 was 57 min, which means that the available time for printing
should be around 1 hour. However, as shown in Figure 3.5, cCMC 1:2 was not printable
after 30 min. We believe that this is caused by the undermixing of the gel solution and the
crosslinker leading to localized gelation in the syringe due to increased thiol concentration.
Vigorous mixing such as vortex is not suitable for viscous ink formulations, and ink can
gel during gentle, but longer, mixing process. Due to these concerns, cCMC 1:2 was
eliminated from further study.
Our results indicate that the thiol to norbornene ratio (T:NB) of the bioink
formulation, controlled by the crosslinker concentration, also affects the mechanical
properties of the hydrogel (Figure 3.4A). Normally, at the molecular level, increasing
crosslinker concentration leads to an increase in the compressive modulus (Young’s
modulus, E). Thus, as expected the E values increased significantly with increase in (T:NB)
from (1:4) to (1:2) for both cCMC and NorCMC.
For each bioink formulation, we compared the cell viability with culture time for
each cell line. For instance, hMSC viability decreased from 96% at Day 1 to 90% at
Day 4, and to 84% at Day 7 for MeHA control group. Note that MeHA is not degradable,
and this could potentially eliminate the ability of the hMSCs to spread and proliferate.
However, hMSC viability was not significantly different for other degradable formulations,
such that cell viability remained stable within 92-93% interval for cCMC (1:4), 95-97%
interval for NorCMC (1:4), and 97-93% interval for NorCMC (1:2). When NIH 3T3 cells
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are considered, cell viability decreased for NorCMC (1:2) from 92% at Day 1 to 83% at
Day 7, and for MeHA from 97% at Day 1, to 88% at Day 4, and to 87% at Day 7. Cell
viability did not show a significant change and remained constant within 93-83% for cCMC
(1:4) and within 91%-83% for NorCMC (1:4). For HUVECs, cell viability decreased from
93% at Day 1 to 86% at Day 7 for NorCMC (1:4) and from 91% at Day 1 to 86% at Day
7, whereas the changes were not significant between Day 1 and Day 4 (including cCMC
group), and Day 4 and Day 7. Cell viability for MeHA group remained within 97-93%.
Our results showed that the decrease in cell viability for the NorCMC and cCMC
formulations is not trivial, and dependent on the cell type and culture period. As we did not
use any commonly used cell-adhesive peptides (such as RGD), we believe that cell
variability could potentially be further enhanced, if needed. We also compared the cell
viability between sample groups (bioink formulations) for each cell line at each culture
Day. For hMSCs, cell viability for cCMC (92%) was lower than that for NorCMC (1:4)
(97%) at Day 1. No significant difference was observed between sample groups at Day 4.
However, cell viability for MeHA (84%) was lower than that for NorCMC (1:2) (93%) and
for NorCMC (1:4) (97%) at Day 7. For 3T3 cell line, cell viability for MeHA (97% at
Day 1, 87% at Day 7) was higher than that for NorCMC (1:2) (92% at Day 1, 83% at
Day 7) and NorCMC (1:4) (91% at Day 1, 83% at Day 7) at Day 1 and Day 7. When
HUVECs are considered, cell viability for MeHA (98%) was higher than cell viability for
NorCMC (1:2) (91%) and NorCMC (1:4) (93%) at Day 1. No significant difference was
observed between sample groups at Day 4 and Day 7. We believe that a lower cell viability
at Day 1 could potentially indicate issues during printing process, such as cell damage due
to shear or light exposure. One way to avoid this is to increase the bioink viscosity to protect
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the cells. For instance, MeHA bioinks were much viscous leading to higher cell viability
at Day 1.
The 15% cCMC (1:4) sample degraded and disintegrated by Day-7 while the similar
NorCMC (1:4) did not because of the reduced degradation afforded by the amide
connectivity versus the ester groups connecting the norbornenes to the CMC. Hydrolytic
degradation of the cCMC bulk hydrogels was previously reported, such that for 4% cCMC
with (T:NB) equal to (1:4), 30% mass loss was reported within 24 hour incubation, which
increased to ~50% after 7 days [236]. This behavior was not observed for NorCMC
hydrogels [237]. In good agreement with the swelling data (see above), we observed
differences in the confocal side view images (Figure 3.7B) of the 3D printed samples. For
instance, vertical distribution of the cells within NorCMC (1:4) was about twice thicker
than NorCMC (1:2), which corresponded to the difference in the swelling ratio (23.4 for
NorCMC (1:4), 12 for NorCMC (1:2)). For cCMC (1:4), cells distributed more sparsely
when compared to that for NorCMC. We believe that this was due to hydrogel degradation
as discussed above.

3.5 Conclusions
In conclusion, we report a two norbornene-modified cellulose-based macromers as novel
bioink materials. Polymer concentration and thiol: norbornene ratio (T:NB) were
optimized to prepare printable bioink formulations from cCMC (with (T:NB) = (1:2) and
(1:4)) and NorCMC (with (T:NB) = (1:4)). All the ink formulations were able to
encapsulate cells (hMSCs, NIH 3T3 fibroblasts, and HUVECs), and to be printed as cellladen scaffolds. We believe that these two cellulose-based macromers broaden the bioink
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library and could be further modified to render more desired properties in further practice
and applications.
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CHAPTER 4
POLYESTER-BASED INK PLATFORM WITH TUNABLE BIOACTIVITY FOR
3D PRINTING OF TISSUE ENGINEERING SCAFFOLDS
This chapter has been adapted from the publication:
S. Ji*, K. Dube*, J.P. Chesterman, S.L. Fung, C.Y. Liaw, J. Kohn, M. Guvendiren,
Polyester-based ink platform with tunable bioactivity for 3D printing of tissue engineering
scaffolds, Biomaterials Science 7(2) (2019) 560-570. *Co-1st Author

4.1 Introduction
Over the last decade, 3D printing has become a promising manufacturing approach for a
wide range of medical applications, including dentistry, tissue engineering and
regenerative medicine, medical devices, anatomical models, and pharmaceutics [9, 46,
238]. 3D printing enables fabrication of custom-designed and patient-specific tissue
engineering scaffolds and devices using the patient’s own medical images, which is not
possible with conventional scaffold fabrication techniques [82, 239-244]. In addition,
conventional techniques generally lack precise control of pore size, geometry,
interconnectivity, spatial distribution, and the overall scaffold architecture [245-247].
These are crucial parameters for a biomaterial to promote the vascularization and tissue
ingrowth that are necessary to establish functional integration of the scaffold [190, 191,
248, 249]. However, most devices currently printed using polymeric biomaterials only
serve as a structural support; they permit, but do not promote, biological function [250,
251]. This limitation is due to the lack of bioactivity of common printable polymers, such
as poly(lactic acid) (PLA) and polycaprolactone (PCL). Due to their thermoplastic and
semi-crystalline behavior, PLA and PCL can be easily extruded as filaments for fused
deposition (FDM) printing or directly printed from melt using direct ink writing (DIW).
Semi-crystalline behavior contributes to dimensional stability during melt to solid
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transition and to mechanical properties (stiffness). Both PLA and PCL are extensively used
to 3D print tissue fixation devices and tissue engineering scaffolds, in particular for
musculoskeletal tissue [252, 253]. Although significant progress has been made to develop
novel printable soft material platforms (including hydrogels and elastomeric systems) [70,
168, 254-259], the progress in biodegradable “stiff” polymers is very limited.
From a materials-perspective, a polymeric biomaterial should meet the
requirements for printing to be considered an “ink”. Rheological properties of the polymers
are crucial to determine their printability. For extrusion-based printing, the polymer melt
must flow at the print temperature (Tp) (usually below 250 ˚C for commercially available
printers); thus, the loss modulus (G") must be greater than the storage modulus (G') at
Tp.[13] The melt viscosity should be below 106 mPa·s to allow flow under applied pressure
(usually ≤110 psi for commercially available printers) [260]. In addition, the polymer must
have a reversible and fast melt to solid phase transformation (within minutes) to rapidly
melt in the hot nozzle and to rapidly solidify when extruded from the nozzle [261].
In addition to printability, the ideal polymeric biomaterial should have sufficient
mechanical properties (stiffness, toughness, etc.) to provide structural integrity, thereby
enabling direct implantation, and should be biodegradable to allow replacement of the
scaffold by newly grown tissue [262-265]. The latter requires the use of polymers that
hydrolytically or enzymatically degrade to biocompatible, resorbable monomers that can
be easily excreted from the body.
Finally, polymeric biomaterials often require bioactivity to control cell function,
including cell migration (infiltration), proliferation, and phenotype preservation or
differentiation [15, 266-268]. Naturally occurring polymers usually display inherent
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bioactivity, which is not the case for synthetic polymers. Thus, it is of great interest to
design functionalizable synthetic polymers for 3D printing. Polymers can be functionalized
at the end groups or along the backbone by adding pendant reactive groups, such as
carboxylic acids [269], amines [270], or hydroxyls [271], One of the most commonly
utilized approaches is click-based conjugation chemistry using click-ready pendant groups,
such as alkenes, alkynes, azides, and epoxides [272, 273], Click chemistry has been
employed for a wide range of applications including bioconjugation, labelling, surface
functionalization, polymer synthesis and modification, and hydrogel modification [272,
274-276],
In this study, we developed a novel platform of 3D printable biodegradable
polymers with tunable bioactivity via click-based chemistry for extrusion-based printing,
with printability and stiffness comparable to PLA. A wide range of tyrosine-derived
polycarbonates with tunable properties have been developed previously [277-281], In this
work, the synthetic design was based on 4-hydroxyphenethyl 2-(4-hydroxyphenyl)acetate
(HTy), which is an ester derived from Tyrosol and 2-(4-hydroxyphenyl)acetic acid. Both
compounds are naturally occurring organic molecules found in olive oil [282, 283], HTy
has been shown to be antioxidant, anti-stress, and antibacterial [282, 283], pPhenylenediacetic acid (PDA) was incorporated into the synthetic design to tune thermal
processability by enhancing crystallinity via π-π stacking interactions. To enable
functionalizability, glutamic acid derivatives were incorporated into the synthetic design
without deteriorating printability and stiffness. Glutamic acid is a diacid with a pendant
amine group, which can be easily modified to incorporate various functional groups. In this
study, we focused on alkyne and alkene functionality for commonly utilized click-based
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conjugation chemistry.
To demonstrate the utilization of this novel ink platform, osteogenic differentiation
of stem cells was studied using 3D printed scaffolds. 3D printed scaffolds were
functionalized with azide-Heparin (az-Heparin) via click chemistry. Heparin is a linear
polysaccharide found in most biological tissues. Heparin is known to sequester growth
factors, enzymes, and matrix proteins. Thus, it is extensively used for the sustained release
of growth factors including bone morphogenetic protein-2 (BMP-2) (for up to 20 days)
[284, 285] to enhance bone regeneration.[286] Our results showed a significant increase in
osteogenic differentiation of stem cells when the scaffolds were tethered with heparinbound BMP-2.

4.2 Experimental
4.2.1 Synthetic Procedures
4.2.1.1 Monomer Synthesis.

Monomers including 4-hydroxyphenethyl 2-(4-

hydroxyphenyl) acetate (HTy) (Figure 4.1A), hex-5-enoylglutamic acid (Gluhexenamide)
(Figure 4.1B), and pent-4-ynoylglutamic acid (Glupentynamide) (Figure 4.1C) were
synthesized as described in the experimental section of Appendix C.
4.2.1.2 Polymer Synthesis. A general procedure for the polymer synthesis ((Figure 4.1)
is provided here and further details can be found in the Experimental Section of the
Appendix C. In a round bottom flask, 1 equivalent of diol, 0.97 combined equivalents of
diacid, and 0.33 equivalents of 1,4-dimethylpyridinium p-toluenesulfonate (DPTS) were
combined with dichloromethane (DCM) and magnetically stirred for 15 min. The stirring
reaction mixture was cooled for 30 min in an ice bath and then 2.1 equivalents of N,N’-
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diisopropylcarbodiimide (DIC) were added. The stirring reaction mixture was kept in an
ice bath for 1 hour and then allowed to gradually warm to room temperature overnight.
After 16 hours, the reaction mixture was precipitated by gradually adding isopropanol (5X
DCM volume) while stirring. The precipitate was collected by vacuum filtration,
redissolved in DCM, and reprecipitated using isopropanol, twice. The final precipitate was
collected by vacuum filtration and dried in a vacuum oven at 40 ˚C for 48 hours.
4.2.2 Monomer and Polymer Characterization
The synthesized monomers and polymers were characterized by 1H NMR spectroscopy
using Varian 400 MHz and 500 MHz NMR spectrometers with dimethyl sulfoxide-d6
(DMSO-d6) as solvent and peak shifts referenced to an internal tetramethylsilane standard.
The molecular weight of the monomers was determined by electrospray ionization-mass
spectroscopy (ESI-MS, Thermo Finnigan LCQ Duo). The number average molecular
weight (Mn), weight average molecular weight (Mw), and the molecular weight distribution
of the polymers were determined using gel permeation chromatography using a Waters
2695 GPC apparatus with a guard and 2 columns. Samples were dissolved in HPLC grade
dimethylformamide (DMF) at a 2 mg/mL concentration, filtered through a 0.2 μm syringe
filter, and run at 25 °C using HPLC grade DMF with 0.1% trifluoroacetic acid (TFA) as
the eluent. Molecular weights were calculated relative to polystyrene standards (Mw = 7.2526 kDa).
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C

Figure 4.1 (A) Synthesis of HTy. (B) Synthesis of gluhexenamide. (C) Synthesis of
glupentyamide.

Figure 4.2 General polymer synthesis.
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4.2.3 Thermal Properties
Thermal properties including the glass transition temperature (Tg) and melting point (Tm)
were determined by differential scanning calorimetry (DSC) from the second heating scan
at a 10 ˚C/min heating rate using a Mettler Toledo DSC821. The thermal degradation of
the polymers was studied by thermogravimetric analysis (TGA, Mettler Toledo). The
temperature at which mass loss began in the thermogram was considered as the thermal
degradation temperature (Td).
4.2.4 Compression Molding
Polymer films were fabricated using a Carver press (Carver 2625) at Tg+50 ˚C or Tm +
10 ˚C. Briefly, 0.3 g of polymer powder was placed between two Kapton films in a
preheated steel mold, placed in the Carver press, and compressed using 1000 psi. The
thickness of the films was adjusted by using spacer shims.
4.2.5 Melt Rheology
Melt rheology (Kinexus Ultra+, Malvern Instruments) was used to study solid to melt
transition behaviour and temperature dependent melt viscosity of the polymers.
Compression molded polymer films (500 μm in thickness) were tested using a 20 mm
diameter plate at a constant frequency (1 Hz) with increasing temperature (1 ˚C/min) up to
200 ˚C. Storage modulus (G'), loss modulus (G"), and melt viscosity were recorded with
increasing temperature. The solid to melt transition temperature was defined as the
temperature where G'=G".
4.2.6 Mechanical Properties
Mechanical properties of the polymer films were tested using a mechanical tensile tester
(MTS Sintech/5D Universal Testing Machine) with a 10 N load cell and a 10 mm/min
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displacement rate. The tensile (Young’s) modulus was calculated from the slope of the
tangent drawn at the linear portion of the stress strain curve (0 to 2%). Five samples of each
polymer were tested.
4.2.7 Hydrolytic Degradation
Hydrolytic degradation was studied by incubating scaffolds (5 mm diameter discs) in
1 mL Dulbecco's phosphate-buffered saline (DPBS) with 0.01% sodium azide at 37 ˚C.
The solution was changed weekly for the duration of the study. At each time point, three
scaffolds were separated, washed with DI water, lyophilized, and characterized
gravimetrically for loss in mass and by GPC for Mn and Mw.
4.2.8 Functionalizability
The reactivity of the polymers with glutamic acid derivatives was characterized in bulk
(using polymer solutions) and/or on the surface (using compression molded films).
1H,1H,2H,2H-perfluorodecanethiol was used to investigate reactivity in the bulk and on
the surface for HP5GH and in bulk for HP5GP. Surface reactivity for HP5GH and HP5GP
was also investigated using bovine serum albumin (BSA) and az-Heparin, respectively.
Az-Heparin was synthesized by reacting heparin with imidazole sulfonyl azide (azo
transfer reagent) as described in the Appendix C [287]. Characterization was done by Xray photoelectron spectroscopy (XPS) for surface and 19F NMR for bulk. A quartz crystal
microbalance (Q-sense) was used to monitor the conjugation reaction of az-Heparin and
physical adsorption of BMP-2 on polymer films in real time and the change in frequency
was converted to a change in mass using the well-known Sauerbrey equation [288].
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4.2.9 3D Printing of Scaffolds
A 3D Bioplotter® Starter Series (EnvisionTEC GmbH, Germany) was used to print the
scaffolds. The 3D digital model for the scaffolds was designed and saved as an STL file
using Autodesk® Fusion 360™. The scaffold was designed as a solid cylinder (1 mm in
height and 9 mm in diameter) to fit in a 48-well plate. Perfactory RP software was used to
slice the STL file with 250 μm layer height. The sliced file was transferred to 3D
Bioplotter® and a linear infill pattern with 0.75 mm spacing was created with alternating
0°and 90°rotation between layers. To begin printing, polymer powder was loaded into a
stainless-steel syringe and heated to a printing temperature determined by the thermal
properties of each polymer. Line tests were performed to determine the optimum printing
parameters, including temperature, pressure, and speed. Briefly, a built-in line test protocol
was used to print individual struts using a range of print pressures and speeds at a
predefined print temperature. Print parameters were optimized to print struts with a
350 μm diameter. Scaffolds were characterized by scanning electron microscopy (SEM,
Jeol).
4.2.10 Preparation of Scaffolds for Cell Culture
To investigate stem cell attachment and proliferation, two sets of scaffolds were printed
from PLA, HP, HP5BG, HP5GP, and HP5GH. Scaffolds were sterilized by immersion in
75% ethanol for 30 min, followed by irradiation with a germicidal UV lamp for 1 h per
side. After sterilization, one set was incubated with fibronectin from bovine plasma (20
μg/mL, Sigma), while the other set was incubated in Dulbecco's phosphate-buffered saline
(DPBS). After the incubation solutions were aspirated, the scaffolds were rinsed with
DPBS three times and transferred into non-treated 48-well plates and maintained in 0.5 mL
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of growth media per well for 2 h prior to cell seeding.
For differentiation studies, four groups of HP5GP scaffolds were used. Two of the
groups were functionalized with az-Heparin (HP5GP-Heparin) by incubating the scaffolds
in 200 μL az-Heparin solution (0.15 μg/mL az-Heparin in DI water) with
10 μL of copper sulfate pentahydrate (45 mg/mL) and 10 μL of sodium ascorbate
(112.5 mg/mL) for 24 h. The scaffolds were washed with DPBS 3 times. One of these
sample groups was further functionalized with BMP-2 (HP5GP-Heparin-BMP2) by
incubating the scaffolds in 200 μL BMP-2 solution (7.5 μg/mL) for 1 h. One of the HP5GP
groups was directly incubated with BMP-2 (7.5 μg/mL) for 1 h, washed with DPBS (3X),
and used as a control. All scaffold groups (HP5GP, HP5GP-Heparin, HP5GP-HeparinBMP2, and HP5GP-BMP2) were transferred into growth media 2 h prior to cell seeding.
4.2.11 Cell Culture and Characterization
Human mesenchymal stem cells (hMSCs, Lonza) were cultured in growth media (MEMα (minimum essential medium) supplemented with 10% fetal bovine serum (FBS, Gibco)
and 1% penicillin streptomycin). hMSCs (115,000 cells/mL, passage 3) were seeded from
the top surface (300 μL per scaffold corresponding to 12,500 cells/cm2) and incubated at
37 ˚C for 60 min to allow for cell attachment. Scaffolds were gently turned upside down
and hMSCs were seeded again (300 μL at 115,000 cells/mL) from the top. For cell
attachment and proliferation studies, the cells were cultured for 14 days in growth media.
For differentiation studies, after 2 days of culture in growth media, the media was replaced
with osteogenic induction media (Lonza) and the cells were cultured up to 21 days. Media
was refreshed every 3 days. For control studies with soluble BMP-2, 1 μL of BMP-2
solution (165 μg/mL in DI water) was added into the media with each media change.
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An alamarBlue cell viability assay (Invitrogen) was used to investigate cell viability
at 2, 4, 7 and 10 days of culture for each group (6 samples per group). To quantify double
stranded DNA (dsDNA), Quant-iT™ PicoGreen™ dsDNA assay kit (Invitrogen) was used.
For this purpose, 3 samples per group were collected at culture Day 1, 4, 7, 10, and 14. The
cells from each sample group were lysed and stored at -80 ˚C until all time points were
collected for quantification. For both assays, an Infinite M200 Pro (Tecan) plate reader was
used.
To visualize cells on the scaffolds, cells were washed with DPBS, fixed in 4%
formalin for 15 min, and incubated in Triton X-100 solution (0.25% Triton X-100 in DPBS)
for 15 min to permeabilize the cell membrane. Cells were stained for F-actin using Alexa
Fluor™ 488 Phalloidin (1:40 in DPBS, Molecular Probes) and nuclei by 4', 6-diamidino2-phenylindole (1:2000 in DPBS, DAPI, Invitrogen). For differentiation studies, cells were
stained for alkaline phosphatase (ALP) with Fast Blue RR/naphthol solution (Sigma), for
calcium deposition with alizarin red (AR) or immunostained for osteocalcin (OC). For
fluorometric quantification of AR staining, cells were de-stained using 10%
cetylpyridinium chloride in 10 mL sodium phosphate (10 mM, pH 7). For immunostaining,
cells were rinsed with DPBS (3X) and incubated in blocking solution (10% goat serum in
DPBS) for 30 min after the permeabilization step. Samples were incubated with the OC
primary antibody (1:200, monoclonal mouse, Fisher Scientific Co.) in staining solution (3%
BSA, 0.1% Tween-20, 0.25% Triton-X) overnight at 4 ˚C. After washing with 3% BSA
solution, cells were incubated in Alexa Fluor 488 rabbit anti-mouse secondary antibody
(1:100, Fisher Scientific Co.) in a 3% BSA solution. Cells were imaged by confocal
microscopy (confocal and 2-photon system, Leica). The nuclei of the OC and ALP stained
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cells were counted using ImageJ to determine OC and ALP positive cells.
4.2.12 Statistical Analysis
The data were analysed using KleidaGraph. Data are presented as mean ± standard
deviation. ANOVA with Tukey’s HSD post hoc test of means was used to make
comparisons between sample groups. (n≥ 3 samples per group).

4.3 Results and Discussion
4.3.1 Monomer and Polymer Synthesis
The HTy monomer was synthesized via Fischer esterification from Tyrosol and 2-(4hydroxyphenyl)acetic acid. HTy degrades hydrolytically to form Tyrosol and 2-(4hydroxyphenyl)acetic acid (Figure 4.1). Since HTy contains phenyl rings, polymers that
incorporate it tend to show semi-crystalline behaviour due to π-π stacking interactions. To
enhance the π-π stacking interactions of HTy-containing polymers and hence their
processability, p-phenylenediacetic acid (PDA) was introduced into the polymer design.
Functionalizability was achieved by incorporating amide derivatives of glutamic acid (GR),
which were synthesized by reacting the dimethyl ester of glutamic acid with alkene or
alkyne carboxylic acids (Figure 4.1). Alkene or alkyne functionality was chosen to enable
click-chemistry for tethering bioactive cues. Poly(HTy-50%PDA) (HP), poly(HTy45%PDA-co-HTy-5%Gluhexenamide)

(HP5GH),

poly(HTy-45%PDA-co-HTy-

5%Glupentynamide) (HP5GP), and poly(HTy-45%PDA-co-HTy-5%BocGlu) (HP5BG)
were successfully synthesized by condensation polymerization of selected combinations of
HTy, PDA, and GR using DIC and DPTS as a catalyst (Figure 4.1). Note that HTy
undergoes 1:1 step growth reaction with PDA and GR during polymerization. Thus, the
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general formula for the functionalizable polymers is poly(HTy(0.5-x)-PDA(0.5-x)-co-HTyxGRx). Although we synthesized three polymer compositions with x = 0.01, 0.05, and 0.10,
x=0.05 was used in this study due to favourable thermal properties, which will be discussed
below. For simplicity, functionalizable polymers are referred to using the following format:
HP5GR, where H, P, and GR denote HTy, PDA, and GR, and the number (5) indicates the
mole percentage of functionalizable GR group. The Mw and PDI of each polymer are given
in Table 4.1. NMR results are given in Appendix C Figure C.1.

Table 4.1 Properties of the Polymers
Polymer

M wa

PDIa

(kDa)

Tgb

Tm1b

Tm2b

T Dc

E Td

σyd

ηe

G’ fold

%Mw

(˚C)

(˚C)

(˚C)

(˚C)

(GPa)

(MPa)

(mPa.s)

changee

Retentionf

p(HTy)

181

1.8

54

-

-

350

2.4(±0.3)

38(±7)

5x106

1.1

-

HP

143

1.7

50

131

147

320

2.1(±0.3)

28(±3)

5x105

3.5

88

HP5BG

141

1.7

46

125

141

330

1.9(±0.1)

40(±3)

3.3x102

4.0

70

HP5GH

126

1.6

47

128

143

320

2.2(±0.1)

34(±6)

1.8x103

4.0

18

HP5GP

129

1.6

50

127

144

320

2.3(±0.1)

38(±2)

2.4x103

4.0

18

a

From DMF GPC, relative to PS standards. bFrom DSC measurements. cFrom TGA. dFrom
tensile tests using compression molded films. eFrom melt rheology using compression
molded films (η measured at 180 ˚C). fFrom hydrolytic degradation tests (8-week point)
using DMF GPC

4.3.2 Thermal and Mechanical Characterization
Thermal properties of the polymers are summarized in Table 4.1. For poly(HTy carbonate)
(p(HTy)), the Tg was observed at 54 ˚C. A shallow melting peak observed at 130 ˚C during
the first heating cycle disappeared in the second heating cycle, thus indicating an
amorphous behaviour. The lack of crystalline behaviour could be due to the rigidity of the
carbonate bonds in the polymer backbone preventing the randomly oriented HTy repeating
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units from aligning for π-π stacking interactions. When PDA was incorporated into the
polymer design to form HP, the Tg dropped slightly to 50 ˚C and two distinct melting
transitions were observed at Tm1 = 131 ˚C and at Tm2 = 147 ˚C (Figure 4.3). Replacing the
carbonate bonds with PDA increases backbone flexibility and the appearance of two
melting points may indicate the presence of distinct crystalline regions formed by either
HTy or PDA π-π stacking interactions. HP5BG, HP5GH, and HP5GP all have similar
thermal properties to HP with Tg, Tm1, and Tm2 values within 4-6 ˚C (Figure 4.3). All of the
polymers decomposed at temperatures between 320-350 ˚C. Note that polymers containing
5 mole % GR were used in this study as the resulting polymer becomes amorphous for 10
mole% GR. The average tensile Young’s modulus values of the polymers were in the range
of 1.9 to 2.4 GPa with yield stress values from 28 to 40 MPa (Table 4.1). Both values were
not statistically different when compared for each polymer.

HP5BG

HP5GP

HP5GH

Heat Flow (W/g)

HP

0

50

100
Temperature (˚C)

Figure 4.3 DSC thermograms for the polymers.
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4.3.3 Hydrolytic Degradation
Polyesters undergo hydrolytic degradation due to the ester bonds in their backbone. The
hydrolytic degradation of compression molded polymer films (HP, HP5BG, HP5GP, and
HP5GH) was studied at 37 ˚C in DPBS (Figure 4.4). For HP, a steady decrease in Mw was
observed between weeks 5 and 22, reaching undetectable Mw values after 22 weeks. For
HP5BG, a generally linear decrease in Mw was observed for the entire 25-week study. The
Mw decreased much faster for HP5GP and HP5GH, such that only 18% Mw was retained
after 8 weeks. We believe that this result could be due to less bulky side groups as compared
to Boc in HP5BG. There are only a few semi-crystalline polymers that show a comparable
high rate of degradation, such as poly(glycolic acid) (PGA) (degradation rate of 3-4 months)
[289]. There was no significant mass loss for HP and HP5BG, which could be due to the
hydrophobic nature of the polymer limiting the solubility of the degraded chains
(Figure 4.4B). The rate of mass loss for HP5GH and HP5GP was 3% and 2.5% per week,
respectively. We did not observe any significant change in Young’s modulus values of
HP5GH and HP5GP up to 4 weeks (Appendix C, Figure C.6).
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Figure 4.4 Hydrolytic degradation of polymers over 25 weeks at 37 ˚C in DPBS. (A)
Percent retained molecular weight (% Mw) with time. (B) Percent mass retention with time.
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4.3.4 Functionalizability
In this study, three distinct polymers were developed with pendent reactive groups. HP5GH
and HP5GP have alkene and alkyne pending groups capable of click chemistry. The alkyne
group can participate in copper catalysed alkyne-azide cycloaddition (CuAAC) reaction,
utilized extensively in the literature [272, 274-276]. The alkene group can react with
sulfhydryl containing compounds in the presence of a photoinitiator and UV light or via
Michael-type addition reaction [290]. HP5BG contains Boc-protected amine groups
capable of carbodiimide chemistry, which also enables functionalization with a wide range
of side chain derivatives to further tether bioactive cues.
The reactivity of the alkene-containing HP5GH was tested by using a small thiolcontaining molecule (1H,1H,2H,2H-perfluorodecanethiol) and a large protein, BSA (66.5
kDa), containing cysteine residues (Figure 4.5). A highly fluorinated small molecule
enabled the study of the reactivity of the polymer in solution via 19F NMR and the reactivity
of the polymer surface (using compression molded films) via XPS. 19F NMR showed that
approximately 94% of the alkene bonds were converted to thioether bonds after UV
irradiation in the presence of a photoinitiator, Irgacure 2959 (Appendix C, Table C.1).
For the surface reaction, XPS data showed that the fluorine peak was only observed in the
presence of UV light exposure, whereas the peak was missing for HP5GH sans UV
exposure and for HP (without the pendent alkene group) with UV exposure (Figure 4.5A).
The effects of thiol concentration, photoinitiator concentration, and UV irradiation time on
the reaction yield for compression molded films were studied in detail, and the results are
summarized in Table C.1. QCM studies indicated that 700 ng/cm2 of BSA was chemically
tethered onto the surface of HP5GH with UV exposure, which was significantly more than
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the 100 ng/cm2 of BSA physically adsorbed onto the surface in the absence of UV exposure
(Figure 4.5B). The reactivity of the alkyne-containing HP5GP was studied via a CuAAC
reaction using az-Heparin. The reaction was monitored in real-time by QCM. 1 µg/cm2 of
az-Heparin was found to be conjugated to the surface of the polymer within 1 hour
(Figure 4.6). Although az-Heparin was found adsorb onto the HP5GP and HP surface
(polymer without a reactive pendent group) in the absence of the catalyst, the amount of
adsorbed az-Heparin was significantly lower: 480 ng/cm2 for HP5GP and 100 ng/cm2 for
HP (Appendix C, Figure C.7). Heparin is known to bind and release growth factors such
as bone morphogenetic protein-2 (BMP-2). To further investigate the activity of tethered
heparin, we studied the interaction of it with BMP-2. Approximately 1 µg/cm2 of BMP-2
was found to bind to the heparinated polymer surface and remained bound after rinsing
with DPBS for 10 h, indicating a strong association of BMP-2 with heparin. The ionic
interaction between the BMP-2 and heparin was disrupted when a surfactant (SDS) was
introduced.
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(A)

(B)
Areal Mass (ng/cm2)

(+)UV

(-)UV

Experiment Time (a.u.)

Figure 4.5 (A) XPS spectra for HP5GH (green), HP reacted with 1H,1H,2H,2Hperfluorodecanethiol under UV light (red), and HP5GH reacted with 1H,1H,2H,2Hperfluorodecanethiol under UV light (blue). (B) QCM data showing the change in areal
mass with time for HP5GH covered with BSA solution in the presence (+) or absence (-)
of UV light.

PBS
wash

PBS
wash

Az-Hep

BMP-2

Figure 4.6 QCM data showing the change in frequency with time for HP5GP. Az-Heparin
was flowed over HP5GP film for 60 min, followed by DPBS for 240 min, then BMP-2 for
100 min, and finally DPBS.
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4.3.5 Rheological Characterization
The rheological properties of polymers are crucial to determine their printability. For
extrusion-based printing at elevated temperatures, the polymer melt must flow at the print
temperature (Tp), thus, the loss modulus (G") must be greater than the storage modulus (G')
at Tp. In addition, the polymer must have a fast melt to solid phase transformation (within
minutes) to rapidly melt in the hot nozzle and rapidly solidify when extruded from the
nozzle [13, 261]. For instance, PLA, the most widely used polymer in 3D printing, shows
a fast phase transformation, indicated by a sharp drop in G' within a very narrow
temperature window (Figure 4.7). For commercial PLA, solid to melt transition occurred
at Tsm = 180 ˚C and melt viscosity was equal to 8.4×105 mPa·s above 180 ˚C (usual printing
temperature). For p(HTy), Tsm = 140 ˚C, with a shallow drop in G' and a relatively high
melt viscosity value (η = 5×106 mPa·s). For HP, η was significantly reduced to 5×105 mPa·s
with a significant drop in G' during solid-to-melt transition (at Tsm = 150 ˚C) (Figure 4.7),
which is consistent with the impact of incorporating PDA on the thermal properties. Note
that the melt rheological behaviour of HP was similar to PLA. Functionalizable polymers
showed extended transition regions with Tsm = 150 ˚C, 140 ˚C, and 138 ˚C, and η = 3.3×102
mPa·s, 1.8×103 mPa·s, and 2.4×103 mPa·s (measured at 180 ˚C), for HP5BG, HP5GH, and
HP5GP, respectively (Figure 4.7). This result could be due to hydrogen bonding
interactions between the amide groups present in the glutamic acid derivatives. The melt
rheological data for all polymers are given in Table 4.1.
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Figure 4.7 Plots showing the change in storage modulus (G’) and loss modulus (G”) of the
polymers with temperature (T). Solid to melt transition temperature is defined as the
temperature where G’=G”.

4.3.6 3D Printing
An EnvisionTEC 3D Bioplotter®, an extrusion-based printer, was used to print the
polymers. Initial extrusion tests were performed to determine the lowest print temperature
(Tp) and polymer incubation time to equilibrate the print temperature (te). Following this
study, printing parameters including print pressure (P) and print speed (νp) were determined
by performing line tests using two needle sizes. The summary of printing parameters to
create 350 μm diameter print lines (struts) is given in Table 4.2. 3D scaffolds printed from
HP, HP5BG, HP5GP, and HP5GH showed identical resolution when compared with
scaffolds printed from PLA (Figure 4.8). SEM images showed self-supporting scaffolds
constructed from uniform 350 μm diameter struts.
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Table 4.2 Printing Parameters, including Needle Diameter (d), Print Temperature (Tp),
Time to Equilibrate Temperature (te), Print Pressure (P), and Print Speed (νp)
Polymer
d (mm)
Tp (℃)
te (h)
P (bar)
νp (mm/s)
PLA
0.3
200
0.5
7
2
HP
0.3
190
1
7
2
0.3
170
1
7
2
HP5BG
0.4
170
1
6
13
HP5GH
0.3
170
1
7
3
0.3
175
0.5
7
1.5
HP5GP
0.4
175
1
6
4

Figure 4.8 Top row: 3D printed scaffolds from PLA, HP, HP5BG, HP5GP, and HP5GH.
The corresponding SEM images including from top view and cross-section are shown in
middle and bottom row, respectively. Scale bars are 200 μm for SEM images.

4.3.7 Stem Cell Culture and Osteogenic Differentiation
hMSCs were cultured on 3D printed scaffolds for up to 14 days. Cells showed gradually
increasing metabolic activity for the first 10 days, and total cell number (measured by
dsDNA content) increased gradually starting from days 4 and 7 (Figure 4.9). Confocal
images of the scaffolds at Day 14 showed that cells had attached and spread uniformly to
cover the struts (Figure 4.9C).
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Figure 4.9 (A) Average peak intensities from alamarBlue cell viability assay for hMSCs
cultured on scaffolds. (B) Average dsDNA quantities found within each scaffold group.
Error bars represent the standard deviation (n = 6 and 3 samples/group for A and B,
respectively). (C) Scanning fluorescent confocal 3D reconstructions of F-actin (green) and
DAPI (blue) stained hMSCs cultured on the scaffolds for 14 days. Scale bars are 200 μm.

To utilize our functionalizable polymeric biomaterial ink platform, we studied the
effect of heparin-tethered BMP-2 on osteogenic differentiation of hMSCs in osteogenic
induction media up to 21 days. For this purpose, we printed scaffolds from HP5GP and
functionalized them with az-Heparin ((+)Hep). One set of the (+)Hep group was then
tethered with BMP-2 ((+)Hep-BMP2). Unfunctionalized HP5GP was used as a negative
control. In addition, we included a positive control group where soluble BMP-2 ((+)sBMP2)
is introduced into the media during media changes. Cells were stained for OC (Figure
4.10A) and ALP (Figure 4.10B) as markers of osteogenic differentiation. Alizarin Red
(AR) staining was also used to qualitatively and quantitatively determine calcium
deposition. When the cells were quantified at day 14, 85±3% and 80±4% of the cells
stained positive for OC for (+)Hep-BMP2 and (+)sBMP2, respectively, which were
significantly higher than (+)BMP2 (68±4%), (+)Hep (58±6%), and HP5GP (56±8%). At
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day 21, (+)Hep-BMP2 and sBMP2 groups reached 93±4% and 100±5% as compared to
(+)BMP2 (77±18%), (+)Hep (57±4%), and HP5GP (62±4%). Increased expression of OC
suggested osteogenic differentiation was upregulated when HP5GP was functionalized
with Heparin-BMP2 (Figure 4.10C). The (+)Hep-BMP2 group also showed significantly
higher ALP positive cells (57±3%) as compared to other groups at day 14 (Figure 4.10D).
When calcium deposition was characterized using AR staining, AR concentration
increased significantly from ~0.1 to 0.5 mM for 14- and 21-day culture respectively, yet
the sample groups did not show any significant differences (Figure 4.10E). A longer
culture period may be required to see significant changes.
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Figure 4.10 (A) Confocal images of hMSCs cultured on 3D printed scaffolds for 14 days
in osteogenic differentiation media, and immunostained for human osteocalcin (OC)
(green). Cell nuclei are stained with DAPI (blue). (B) Brightfield images of hMSCs stained
for alkaline phosphatase (ALP, dark blue/purple) after 14 days of culture in osteogenic
media. (C) Percentage of cells stained positive for OC corresponding to (A). For Day 14,
#
p<0.2 for Hep-BMP2 as compared to HP5GP and (+)Hep, #p<0.5 for Hep-BMP2 as
compared to (+)BMP2. For Day 21, p<0.02 sBMP2 group as compared to HP5GP, (+)Hep,
and (+)BMP2, and *p<0.4 for (+)Hep-BMP2 as compared to HP5GP and (+)Hep. (D)
Percentage of cells stained positive for ALP corresponding to (B). *p<0.001 for (+)HepBMP2 as compared to other sample groups (n=3). (E) Alizarin Red (AR) staining
quantification results using fluorometric analysis depicting AR concentration (mM) for
each scaffold after 14 and 21 days of culture in osteogenic induction media.

4.4 Conclusions
We used a bottom-up synthetic design approach to develop novel 3D printable polymeric
biomaterials for extrusion-based printing from biodegradable stiff polymers with tunable
functionalizability. The polymer designs were based on the hydrolytically degradable
monomer HTy, which is synthesized from two naturally occurring olive oil components
(Tyrosol and 2-(4-hydroxyphenyl)acetic acid). Despite the presence of phenyl rings, p(HTy)
was generally amorphous and not printable using commercially available 3D printers.
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Introducing PDA into the synthetic design resulted in the HP copolymer, which showed
crystalline behaviour due to enhanced π-π stacking interactions. The thermal processing
properties of HP were almost identical to PLA, the gold standard for extrusion-based
printing for biomedical applications. Functionalizability was achieved by incorporating
glutamic acid derivatives (GR) into the synthetic design and generating copolymers of HTy,
PDA, and GR. Our results showed that 5 mole% of GR addition did not significantly alter
thermal properties, stiffness, and printability of these polymers. In this study, we
particularly focused on functionalizable polymers enabling click-based conjugation
chemistry via alkyne (HP5GP) or alkene (HP5GH) functionality. We successfully
demonstrated the reactivity of these functional groups in bulk (using polymer solutions)
and on the surface (using polymer films). 3D scaffolds fabricated from these polymers
showed uniform strut distribution within the scaffolds, with strut resolution identical to that
of PLA. When cultured on these scaffolds, hMSCs were highly viable, and uniformly
attached and spread on the struts. To further demonstrate the utility of the functionalizable
polymers, we studied the osteogenic differentiation of hMSCs on HP5GP scaffolds
functionalized with az-Heparin and BMP-2 ((+)Hep-BMP2). Our results showed a
significantly higher fraction of the hMSCs stained positive for ALP and OC, which are
osteogenic markers for stem cells.
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CHAPTER 5
3D PRINTING WAVY SCAFFOLDS FOR ENHANCED MSC OSTEOGENESIS
This chapter has been adapted from the publication:
S. Ji, M. Guvendiren, 3D Printed Wavy Scaffolds Enhance Mesenchymal Stem Cell
Osteogenesis, Micromachines (Basel) 11(1) (2019).

5.1 Introduction
There is a growing interest in developing porous scaffolds for bone tissue engineering
enabling temporary mechanical support for cells to attach, migrate and produce newly
formed extracellular matrix to ultimately form a functional bone tissue [291-293].
Although bone has a robust regenerative ability, therapeutic interventions are required for
large bone defects [294, 295]. Grafts (autografts, allografts, and xenografts) are commonly
used in clinic to fill the defect site and to regenerate bone tissue [296, 297]. Porous scaffolds
can be considered as an alternative to regenerate bone while mechanically supporting the
defect site [298]. A wide range of techniques have been developed to fabricate porous bone
scaffolds, such as gas foaming [299-301], solvent casting and particle/salt leaching [302306], phase separation [307, 308], freeze drying [309, 310], and electrospinning [311-313].
However, the majority of these techniques fail to precisely control the 3D architecture of
the scaffolds, including pore size and pore distribution, and also fail to develop
reproducible scaffolds [291]. 3D printing is an additive manufacturing technique and
enables fabrication of custom-designed and highly complex 3D scaffolds. 3D printing
allows the use of patient’s own medical images to design personalized scaffolds that are
anatomically similar to the defect site. Thus, it has been widely utilized for fabricating
custom-designed bone scaffolds [82, 145, 314-316]. A wide range of 3D printing
techniques have been used to fabricate 3D bone scaffolds, such as fused deposition
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modeling (FDM) [78, 317-319], direct ink writing (DIW) [320, 321], selective laser
sintering and melting (SLS and SLM) [322], stereolithography (SLA) [323-325],
continuous digital light processing (cDLP) [326, 327], and inkjet printing [328, 329]. These
3D printing technologies allow to utilize various printable materials [41] and designs [330].
Computational tools have also been utilized to optimize scaffold architecture to achieve
enhanced permeability and mechanical properties [331-335].
Mesenchymal stem cells (MSCs) are regarded as a clinically relevant cell source
for bone tissue engineering due to their ability to proliferate and migrate as well as their
potential to differentiate into osteogenic lineage (bone) [336-339]. Stem cells are known to
feel and respond to their microenvironment by regulating their function [174, 340-342].
Materials-based approaches have been developed to engineer extracellular matrix (ECM)
mimetic microenvironments [15, 343, 344], including macro- and nano-scale topographical
cues to control stem cell behavior [345, 346]. Topographical cues alone have been shown
to control stem cell response, such as morphology, alignment, proliferation, migration,
cytoskeletal organization, focal adhesion, nuclear deformation, and differentiation [346348]. For example, human MSCs (hMSCs) are shown to produce bone mineral when
cultured on substrates with the nanoscale disorder [349]. Nano-scale roughness is shown
to enhance MSC osteogenesis even in the absence of induction media [350, 351]. This
phenomenon is shown to be due to clustering of absorbed proteins on nano-topography,
which promotes integrin-mediated focal adhesions enhancing cellular contractility and
stem cell osteogenesis [350]. Micro-scale patterns confining stem cells within celladhesive regions were used to control stem cell shape or cellular spreading. For instance,
McBeath et al. showed that hMSCs with spread morphology led to actin-myosin-generated
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tension and promoted osteogenic differentiation [352]. Increasing cellular contractility, or
cytoskeletal tension, by changing the shape of the multicellular sheets, Ruiz and Chen were
able to enhance osteogenic differentiation of hMSCs [353]. Mrksich and co-workers
showed that stem cells residing on curved surfaces became highly contractile and
differentiated to osteogenic lineage [354]. Lineage commitment of hMSCs on hydrogel
wrinkling patterns was determined by the pattern morphology, such that hMSCs on
lamellar patterns formed spread morphology with a high cell aspect ratio (>4) differentiated
into osteogenic progenitors [355]. When porous 3D scaffolds are considered, pore
architecture, surface topography and interconnectivity are shown to control osteogenic
differentiation of human mesenchymal progenitor cells [356]. Simon and co-workers
fabricated 2D films and 3D porous scaffolds with different techniques (gas foaming, salt
leaching, phase separation, electrospinning, 3D printing, and spin coating) to examine the
seeded hMSCs osteogenesis, which indicated that the scaffolds could be optimized to
control the cell morphology to direct differentiation [357]. Recently, DIW was used to
create 3D scaffolds with distinct architectures composed of square (SQR), hexagonal
(HEX), or octagonal (OCT) patterns [358]. Human MSCs were reported to exhibit higher
cell aspect ratio and mean cell area on OCT scaffolds as compared to SQR and HEX
scaffolds, and hence, showed significantly enhanced osteogenic differentiation. Although,
the effect of curvature is well documented in 2D, it has not yet been studied systematically
in 3D.
In this work, we used 3D printing to fabricate wavy poly(caprolactone) (PCL)
scaffolds to investigate the effect of curvature on hMSC osteogenesis. A sinusoidal
waveform was used to create wavy scaffolds. The wavelength and amplitude of the
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sinusoid were systematically varied to design five distinct wavy scaffolds. Orthogonal
scaffold with straight struts was used as a control. First, we investigated the effects of
scaffold architecture on stem cell growth, including cell attachment, proliferation, and
shape (spreading). Then, we studied the osteogenic differentiation of hMSCs on wavy
scaffolds as compared to commonly used orthogonal architecture. The main hypothesis
behind this study is that the wavy scaffolds can direct a more elongated and stretched stem
cell morphology resulting in highly organized cytoskeletal arrangement with high
contractility. This could lead to an increased osteogenesis, the degree of which can be
controlled by the degree of the curvature or waviness.

5.2 Materials and Methods
5.2.1 Scaffold Design
Autodesk® Fusion 360™ (Autodesk Inc., San Rafael, CA, USA) was used to design the
3D models. The basic 3D model was designed as a cylinder with a diameter of 15 mm and
a height of 1 mm. The 3D model (.stl file) was then loaded into Perfactory RP for slicing,
with a layer height equal to 0.25 mm. The sliced file (.bpl file) was loaded into Visual
Machine, and the infill patterns were selected. A linear pattern was selected for the
orthogonal scaffolds (i.e., the control group), and a sinusoidal waveform was selected for
the wavy scaffolds (Figure 5.1). For wavy scaffolds, the amplitude and the wavelength of
the sinusoid were varied systematically to develop 5 distinct scaffold designs (Table 5.1).
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Figure 5.1 Wavy scaffold design containing four layers (left) and schematic showing the
strut design for wavy scaffolds (right).

Table 5.1 Design and Printing Parameters for the Scaffolds
Parameter

Orthogonal

A0.5W2

A0.5W3

A0.5W4

A0.75W4

A1W4

Amplitude (mm)

-

0.5

0.5

0.5

0.75

1

Wavelength (mm)

-

2

3

4

4

4

Strut Diameter (μm)

533±9

497±73

490±36

513±30

510±32

460±58

Strut Spacing 1 (μm)

395±6

277±59

350±53

396±72

308±120

336±103

Struts Per Layer

16

15

15

15

15

15

Temperature 2 (℃)

80

80

80

80

80

80

Print Pressure (bar)

7

7

7

7

7

7

Print Speed (mm/s)

4

4

6

5

5

5

E (MPa)

12.4±0.3

10.5±0.5

11.5±0.2

9.5±0.2

10.7±0.2

11.3±0.5

Porosity 4 (%)

56.3±0.7

56.5±1.2

55.9±0.3

61.7±0.9

57.6±0.5

57.2±3.1

3

Strut-to-strut distance. Print temperature. Young’s modulus from compression tests. 4
Micro-CT results.
1

2

3
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5.2.2 3D Printing of Scaffolds
3D Bioplotter (EnvisionTEC) was used to print the scaffolds using PCL pellets (MW = 55
kDa, Polysciences Inc). The print temperature and pressure were set to 80 ℃ and 700 kPa
(7 bar), whereas the print speed was varied from 4 to 6 mm/s for each design to achieve
(see Table 5.1 for actual values for each design).
5.2.3 Characterization of the Scaffolds
3D printed scaffolds were imaged by using a scanning electron microscope (SEM, JSM7900F, JEOL) and a micro-computed tomography scanner (micro-CT, SkyScan 1275,
Bruker). SEM images were used to measure the strut size and the strut-to-strut distance.
Micro-CT was used to measure the porosity of the scaffolds. Compression tests were
performed on 3D printed scaffolds using an Instron model 3343 with a 1000 N load cell
and a 0.5 mm/min displacement rate. Three samples for each scaffold group were tested.
5.2.4 Preparation of the Scaffolds for Cell Culture
Scaffolds were sterilized by immersing them in 75% ethanol for 30 minutes, followed by
1-hour UV exposure (by a germicidal lamp) for each side of the scaffold. Scaffolds were
then incubated in 20 μg/mL fibronectin solution in 300 μL (bovine fibronectin plasma,
Invitrogen) overnight to enhance cell attachment. Fibronectin solution was removed, and
scaffolds were washed with Dulbecco's Phosphate-Buffered Saline (DPBS, Gibco), moved
into a new well, and kept in growth media prior to cell seeding.
5.2.5 Cell Culture and Reagents
Human mesenchymal stem cells (hMSCs, passage 4, Lonza) were cultured in growth media
(α-MEM (minimum essential medium) supplemented with 10% fetal bovine serum (FBS,
Gibco) and 1% penicillin-streptomycin (pen-strep, Gibco). Prior to seeding, each scaffold
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was removed from growth media and placed in a single well in a non-treated 24-well plate.
The hMSC suspension (133,000 cells/mL) were seeded from the top of the scaffolds
(300 μL per scaffold, corresponding to approximately 5,000 cells/cm2). Cells were
incubated at 37 °C for 60 min to allow cell attachment. Scaffolds were then flipped, and
the same amount of cell suspension was seeded from the top, followed by 60 min
incubation at 37 °C. The scaffolds were then transferred to a new non-treated 24-well plate,
and 1 mL of fresh growth media was added to each well. The scaffolds were incubated for
7 days in growth media. For osteogenic differentiation studies, growth media was replaced
with osteogenic induction media (hMSC osteogenic differentiation medium BulletKitTM,
Lonza) at Day 7, and cells were cultured for an additional 14 days. The media was refreshed
every 3 days in cell culture studies.
5.2.6 Cell Culture and Characterization
For stem cell growth studies, alamarBlue assay (alamarBlue™ Cell Viability Reagent,
Invitrogen) and PicoGreen assay (Quant-iT™ PicoGreen™ dsDNA Assay Kit, Invitrogen)
was used to evaluate the cell proliferation at day 1, 4, and 7, according to manufacturer’s
protocol. Tecan plate reader (Infinite M200 Pro, Tecan) was used to complete the assays
for these studies. To visualize the attached cells on the scaffolds, cells were washed with
DPBS (3X), fixed with 4% formaldehyde for 15 min followed by DPBS wash (3X), and
permeabilization in 0.25% Triton-X DPBS solution for 1 hour. Cells were stained for
F-actin using rhodamine phalloidin (1:40 in DPBS, Invitrogen). Cell nuclei were stained
with 4′,6-diamidino-2-phenylindole (DAPI, 1: 2000 in DPBS, Sigma). At day 7, cells were
immunostained for vinculin using anti-vinculin−FITC antibody (1:50, mouse monoclonal,
Sigma). For this purpose, cells were incubated in 10% goat serum (in DPBS) for 30 min,
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washed with staining solution (3X, 3% bovine serum albumin + 0.1% Tween-20 + 0.25%
Triton-X), and incubated in vinculin antibody in staining solution overnight at 4 °C. Cells
were imaged by using a confocal and multiphoton microscopy (TCS SP8 MP, Leica).
For differentiation studies, calcium deposition was evaluated AT DAY 21 by using
alizarin red staining kit (AR, Sigma). After the staining was completed, cells were washed
with DPBS (3X), and incubated in 10% cetylpyridinium chloride (Sigma) in sodium
phosphate buffer (10 mM, pH 7, Sigma) to remove the stain. This solution was then used
to quantify calcium content by using a Tecan plate reader (scanned at 405 nm). Alkaline
phosphatase activity was studied with QuantiChromTM Alkaline Phosphatase Assay Kit
(ALP assay Kit, BioAssay Systems). Cells cultured within the scaffolds were first lysed
with 0.2% Triton-X followed by 3 freeze-thaw circles. The lysate was then reacted with pNitrophenyl phosphate working solution and scanned at 405 nm using a plate reader
(Infinite M200 Pro, Tecan). For osteocalcin (OC) staining, cells were fixed at Day 14 and
Day 21. Cells were incubated in 10% goat serum (in DPBS) for 30 min, washed with
staining solution (3X, 3% bovine serum albumin + 0.1% Tween-20 + 0.25% Triton-X),
and incubated with the OC primary antibody (1: 200, monoclonal mouse, Invitrogen) in
the staining solution overnight at 4 °C. After removing the antibody-containing staining
solution and washing the samples with fresh staining solution, cells were incubated in
Alexa Fluor 488 rabbit anti-mouse secondary antibody (1: 100, Invitrogen) in staining
solution for 2 hours. Samples were then stained with phalloidin (rhodamine phalloidin,
Invitrogen) and DAPI to visualize F-actin and cell nuclei, respectively. Cells were imaged
by using a confocal and multiphoton microscopy (TCS SP8 MP, Leica). All of the collected
images were processed using ImageJ for further analysis.
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5.2.7 Statistics
The data were analyzed using Origin 2016 software. Data were presented as mean ±
standard deviation. One-way ANOVA with Tukey’s HSD post hoc test of means was used
to make comparisons between sample groups (n ≥ 3 samples per group unless otherwise
specified).

5.3 Results
5.3.1 3D Printing of PCL Scaffolds
PCL scaffolds with 6 distinct designs, including one linear design (orthogonal), and 5 wavy
designs in the form of sinusoidal wave with varying amplitude (A) and wavelength (W)
(A0.5W2, A0.5W3, A0.5W4, A0.75W4, and A1W4, where numbers denote for the actual
values of A and W in mm) are printed (Table 5.1). Figure 5.2 shows the pictures, microCT images, and SEM images of the scaffolds. SEM images were used to measure the
printed strut width and spacing between struts for each design, and results were
summarized in Table 5.1 Briefly, the average strut width was within the range of
460 ±58 to 533 ±9 μm, and the spacing between struts (strut-to-strut distance) was within
the range of 277 ±59 to 395 ±6 μm.
5.3.2 Mechanical Tests
Compression tests were performed on each sample group, and the results are summarized
in Table 5.1 and Figure 5.3. The compressive modulus (Young’s modulus, E) of all the
designs were in the range of 9.5-12.4 MPa (Table 5.1). E (9.5 MPa) for the A0.5W4 design
(with the highest porosity, ~62%) was significantly lower than the rest of the sample groups.
The orthogonal design (E = 12.4 MPa and porosity = ~56%) showed significantly higher
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E as compared to A0.5W2 (E = 10.5 MPa and porosity = ~56%), A0.5W4, and A1W4 (E
= 11.3 MPa and porosity = ~57%).

Figure 5.2 Images of the scaffolds. From the top to bottom row, images correspond to
pictures (top view), micro-computed tomography (micro-CT) images (top view), scanning
electron microscope (SEM) images, and SEM cross-section images. Scale bars are 500 μm
for pictures and micro-CT images and 1 mm for SEM images.
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Figure 5.3 Young’s modulus (E) values of the scaffolds for each scaffold design. * p <
0.005 for orthogonal vs. A05W2, A0.5W4, and A1W4; and for A0.5W4 vs. all sample
groups.

5.3.3 Growth Study
The hMSC growth studies were performed by culturing cells in growth media for up to 7
days in growth media. The results for AlamarBlue assay and PicoGreen assay are shown
in Figure 5.4. The AlamarBlue assay results showed that the measured mean intensities
increased from Day 1 to Day 7, which indicated an increased metabolic activity with
culture time. There was an exception for A1W4, which showed a drop from Day 4 to Day
7. At Day 7, no significant difference was observed between the test groups. For the
PicoGreen

assay,

a

similar

trend

was

observed

as

the

mean

value

of

λ-DNA ascended from Day 1 to Day 7. At Day 7, there was no difference between the test
groups. The multiphoton confocal images of the stem cells (F-actin in green and cell nuclei
in blue) cultured on the 3D printed scaffolds for 7 days are given in Figure 5.5. F-actin
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filaments were aligned with the printed struts that form the substrates, and this alignment
was more pronounced in the curved regions in wavy scaffolds.

Figure 5.4 (A) AlamarBlue Assay (n=6); (B) PicoGreen Assay (n=3), *p<0.005
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Figure 5.5 Multiphoton confocal images of the human mesenchymal stem cells (hMSCs)
cultured on the scaffolds for seven days. Cells were stained for F-actin (red) and nuclei
(blue). Scale bars are 200 μm.

5.3.4 Differentiation Study
Osteogenic differentiation of hMSCs cultured on the 3D printed scaffolds was studied for
up to 21 days. Figure 5.6 shows the results from AR staining and assay. The scaffolds with
wavy designs showed more staining (Figure 5.6A) and higher values of mean calcium
deposition (Figure 5.6B). The value of the mean calcium deposition in wavy groups was
in the range of 2.5 to 6 times higher than that of the orthogonal group. Specifically, the
average calcium deposition was equal to 9.33 ± 0.98 mM for A0.75W4, 8.14 ± 2.86 mM
for A0.5W2, 7.60 ± 1.65 mM for A1W4, 6.12 ± 3.07 mM for A0.5W4, 3.96 ± 2.06 mM
for A0.5W3, and 1.53 ± 0.10 mM for orthogonal scaffolds, in descending order. ALP
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activity assay results, at culture Days 14 and 21, are given in Figure 7. Our results showed
an increase in ALP activity for all sample groups from Day 14 to Day 21, and the ALP
activity of the wavy scaffolds was higher than that of the orthogonal group at both Day 14
and Day 21 (Figure 5.7). At Day 14, A0.5W3 (13.16 ±3.17 a.u.) was significantly higher
than the orthogonal group (5.96 ± 1.58 a.u.). At Day 21, A0.5W2 (46.83 ± 7.90 a.u.) and
A0.5W3 (45.51 ± 4.20 a.u.) were much higher than that of the orthogonal group (32.31 ±
0.89 a.u.). Representative fluorescent images showing vinculin staining at Day 7 are shown
in Figure 5.8. We observed more pronounced vinculin fibers that were aligned with the
wavy struts for wavy scaffolds as compared to diffused and randomly oriented vinculin for
the orthogonal scaffold. Figure 5.9 shows the representative confocal images of the
hMSCs cultured on 3D printed scaffolds, in which cells were stained for osteocalcin (OC,
green), F-actin (red), and nuclei (blue) at Culture Day 14 and 21. Osteocalcin staining was
more pronounced on curved struts as compared to linear struts.

Figure 5.6 (A) Optical microscopy images of the hMSCs stained for alizarin red (red) after
culture in osteogenic induction media for 21 days. Scale are 200 μm. (B) Alizarin red
concentration indicating calcium deposition at Day 21. (* p < 0.15, ** p < 0.05, for n = 3).
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Figure 5.7 ALP activity assay results for: (A) Day 14 and (B) Day 21 (* p < 0.15,
** p < 0.05, for n = 3).

Figure 5.8 Multiphoton confocal images of hMSCs that are stained for vinculin (green) at
Day 7.
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Figure 5.9 Multiphoton confocal images for hMSCs that were cultured in osteogenic
induction media for 14 (top row) and 21 days (bottom row). Cells were immunostained for
osteocalcin (green) and stained for F-actin (red) and cell nuclei (blue). Scale bars are 200
μm

5.4 Discussion
In this study, we used extrusion based DIW printing technology to fabricate PCL scaffolds.
DIW allowed us to 3D print scaffolds directly from PCL pellets, which were melted within
and extruded from a steel syringe attached to the print head. PCL was selected as a model
polymer as it is a “Generally Recognized As Safe” (GRAS) polymer by the U.S. Food and
Drug Administration and widely used to 3D print tissue engineering scaffolds for both in
vitro and in vivo studies [82, 322, 359] We used hMSCs as the main cell line due to their
ability to proliferate, migrate, and differentiate into a wide range of tissue specific
phenotypes including bone, cartilage, and muscle. Stem cells are known to feel and respond
to their microenvironment (matrix stiffness, topography, and bioactivity) by regulating
their behavior [15, 174]]. Here, we focused on the topography, or scaffold architecture. To
investigate the effects of 3D scaffold architecture on stem cell osteogenesis, we constructed
scaffolds using struts in sinusoidal waveforms, systematically varying the amplitude and
the wavelength (Figures 5.1 and 5.2, Table 5.1). The sinusoidal waveform design created
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highly curved strut surfaces forming 3D scaffolds with wavy patterns. Our motivation to
create wavy scaffolds was based on previous studies, which clearly showed the importance
of substrate curvature on stem cell osteogenesis [353, 354].
The minimum wavelength and amplitude achievable for a strut size around 500 μm
were 2 mm and 0.5 mm (A0.5W2). While keeping the amplitude constant at 0.5 mm, the
wavelength was increased to 3 mm (A0.5W3) and 4 mm (A0.5W4). For the 4 mm
wavelength, the amplitude was increased to 0.75 mm (A0.75W4) and 1 mm (A1W4). These
geometrical constraints allowed us to create scaffolds with an average strut-to-strut
distance of approximately 350 μm (Figure 5.2, Table 5.1). Note that the effect of pore size
in bone scaffolds has been well studied [305, 314, 360-365], and a minimum pore size of
~150 μm is usually required for cell migration and tissue ingrowth [247, 293, 366, 367].
We then investigated the effect of scaffold design on mechanical properties of the scaffolds
(Figure 5.3). The compressive modulus (E) values were determined by the design, i.e.,
strut-to-strut contacts between layers, and the overall scaffold porosity. E values were
significantly the highest for orthogonal scaffolds (12.5 MPa) mainly because these
scaffolds inherently displayed more strut-to-strut contacts, considering that this design had
16 struts per layer, whereas all the wavy designs had 15 struts per layer. This design also
had one of the lowest porosities with ~56%. When wavy scaffolds were compared, A0.5W4
showed the significantly highest porosity (~62%) corresponding to the significantly lowest
E value of 9.5 MPa followed by A0.75W4 (58%, 10.7 MPa), A1W4 (57% 11.3MPa), and
A0.5W3 (56%, 11.5 MPa). A0.5W2 (56%, 10.5 MPa) was an exception and did not follow
the trend. This was due to reduced strut-to-strut contacts due to the design (Figure 5.2).
Although the overall scaffold modulus determines the mechanical support level that a
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scaffold can provide when implanted, it did not affect the stem cell behavior in our study.
This is because the stem cells feel the mechanics of the individual struts (which was
uniform for all scaffold groups) that they reside on when seeded on to the scaffolds [358].
First, the growth study was conducted to determine the attachment and proliferation
of the hMSCs cultured on our scaffolds. The metabolic activities of the cells were not
significantly different from each other at each culture day, but increased significantly with
culture day, reaching a maximum at Day 7 (Figure 5.4A). The same trend was observed
when the DNA was quantified (Figure 4B). Note that this trend was not true for the A1W4
and A0.75W4 sample groups, for which the metabolic activity reached a maximum at Day
4 and did not change significantly at Day 7. Yet, the DNA count did not show this
unexpected trend for these two sample groups, which represented the cell proliferation
more accurately. F-actin staining at Day 7 confirmed that cells attached onto the struts and
formed confluent layers at Day 7, taking the shape of the struts. Cells on wavy scaffolds
were highly elongated, especially on the curved edges with well-defined F-actin filaments
aligned with the scaffold curvature as compared to much bulkier cells on orthogonal
scaffolds (Figure 5.5). In addition, stem cells on wavy scaffolds showed mature vinculin
(focal adhesion marker) patches as compared to diffused vinculin staining of cells on
orthogonal scaffolds at Day 7 (Figure 5.8). Focal adhesion is a vital step in osteogenesis
[368] in which vinculin directs the interaction between talin and actin to direct the focal
adhesion process [369]. We investigated if these significant changes in stem cell
morphology, F-actin expression, and focal adhesion on wavy scaffolds as compare to
orthogonal scaffolds correlated with stem cell osteogenesis on wavy scaffolds. It was also
noted that the curvature had a direct effect on cell proliferation, and studies have shown
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that curvature induced contractility enhances proliferation and cell growth [370-372]. In
our study, we did not observe a significant difference in proliferation between sample
groups. This was not contradictory to the literature as each of our wavy scaffolds displayed
both concave and convex curvature, and the overall cellular behaviour was collective rather
than distinct for each type of curvature.
The differentiation studies were conducted after the cells reached a confluent state
at Day 7, as shown by the growth studies (Figures 4 and 5). At Day 7, the growth media
was replaced with osteogenic induction media, and cells were cultured for 14 additional
days in induction media, a total of 21 days in culture. To assess the osteogenic
differentiation of hMSCs, we quantified calcium deposition and ALP activity and
performed immunostaining for osteocalcin. The AR assay was used to probe the deposition
of calcium. Optical microscope images revealed that wavy scaffolds showed more stained
regions than the orthogonal group. When quantified, all the wavy scaffolds showed higher
calcium deposition than the orthogonal group, and in particular, two groups (A0.5W2 and
A0.75W4) showed significantly higher calcium deposition (Figure 5.6). These results
indicated that the overall contribution of the curvature on these two scaffolds on cellular
contractility induced calcium deposition was the highest. ALP is a well-known biological
marker for stem cell osteogenesis [373]. ALP activity increased significantly for all of the
scaffold groups from Day 14 to Day 21 (Figure 5.7). All the wavy groups showed higher
ALP activity than the orthogonal group. However, the differences between wavy groups
and the orthogonal group were not as significant as the results from the AR assay. This
could be because the ALP expressed at earlier stages of the osteogenesis process. At Day
14, A0.5W3 showed significantly higher ALP activity (p < 0.05) when compared to the
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orthogonal group. At Day 21, both A0.5W2 and A0.5W3 were substantially higher than
the orthogonal group (p < 0.15). To supplement our quantitative differentiation assays, we
performed OC immunostaining (Figure 5.9) as a marker for osteogenesis. Qualitatively,
we observed increasing OC staining with culture day, and wavy scaffolds showed more
OC staining, in particular in the curved regions of the scaffolds. The enhanced osteogenesis
behaviour on wavy scaffolds could be explained as the effect of the curvature, which led
to a highly aligned and stretched cellular morphology (Figure 5.5) with mature focal
adhesions (Figure 5.8), leading to highly contractile cells promoting osteogenesis. We
strongly believe that our results clearly showed the importance of scaffold architecture on
hMSC osteogenesis and would help to develop novel scaffold architectures for bone tissue
regeneration.

5.5 Conclusions
In this study, we developed 3D printed PCL scaffolds with wavy or linear patterns to
investigate the effects of a wavy scaffold architecture on the osteogenic differentiation of
hMSCs. When cultured in growth media, hMSCs attached and proliferated, forming
confluent layers on the scaffolds within seven days. We found that hMSCs spread by taking
the shape of the curved surfaces and exhibited elongated F-actin filaments and mature focal
adhesion sites (vinculin staining). In contrast, hMSCs were bulkier in shape and showed
dispersed vinculin staining on the orthogonal scaffold. We found that hMSCs showed
significantly higher calcium deposition, higher ALP activity, and significantly pronounced
osteocalcin staining when cultured on wavy scaffolds as compared to orthogonal scaffolds.
These results are important in that they clearly showed the importance of scaffold
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architecture on hMSC osteogenesis and may provide guidance on novel bone scaffold/graft
design for pre-clinical and clinical applications.
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CHAPTER 6
SUMMARY, CONCLUSIONS, AND FUTURE WORK

This dissertation introduced the development of a novel bioprinting approach for
fabricating complex channels within cell-laden hydrogels, a novel bioink platform, and a
novel UV-stimuli bioink platform, and a polyester-based functionalizable biomaterial ink
platform for 3D printing of tissue engineering scaffolds. In addition, the effect of the
scaffold architecture on stem cell differentiation was also investigated.
In Chapter 2, the reported approach is a complementary technique to existing
approaches to fabricate user-defined and tunable channels and does not require rapid solid
to gel transition of the support material (or shear-thinning behavior), which makes it more
applicable for a wide range of commercially hydrogel systems. Since our approach does
not require special chemistries, there are potentially a greater number of commercially
available options for ink materials. Following this study, the approach could be utilized to
fabricate microfluidic cell-laden hydrogel chips as in vitro models for drug screening and
cell behavior studies.
In Chapter 3, the reported norbornene-functionalized bioink platforms, cCMC and
NorCMC, have their advantages in cost-effectiveness, tunability, and cytocompatibility,
broadening the bioink library of 3D bioprinting. However, the current bioink formulations
have autogelation issues that limit the printable window, and it is difficult to print the
bioinks as well-defined structures without support materials. To address these issues, we
have found that the pH of the formulations can significantly postpone the autogelation point.
To improve the printability, the in-situ-photocrosslink printing strategy [121] could be
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applied to print cCMC and NorCMC. In addition, different crosslinkers are capable of
adjusting the mechanical and biochemical properties of the bioinks, which indicates a great
promise of the cCMC and NorCMC in cartilage tissue engineering.
In Chapter 4, the reported polyester-based ink platform, including HP5GH, HP5GP,
and HP5BG, demonstrated great degradability, printability, and cytocompatibility. HP5GP
and HP5GH were successfully functionalized, and HP5GP was selected to test the function
of the ink, which was validated via the osteogenic differentiation study. This novel polymer
platform with tunable functionalizability could be utilized for additive manufacturing of
biodegradable devices and scaffolds with tailored mechanical and bioactive properties for
a wide range of medical applications, including bone fixation devices and scaffolds for
bone regeneration.
In Chapter 5, PCL scaffolds with wavy or linear architectures were printed,
followed by an hMSC osteogenic differentiation study. The results showed hMSCs on
wavy scaffolds had more calcium deposition, ALP activity, and osteocalcin deposition.
Although the impact of the scaffold architecture on hMSC differentiation was clear, and
we had proposed the curvature led to more aligned and stretched cellular morphology, the
quantification of the impact of the scaffold architectures may be simulated with a proper
model, which can further optimize the scaffold design for bone tissue engineering.
However, the presented studies have their limitations, and warrant future
investigation. For the bioprinting approach for fabricating complex channels within cellladen hydrogels, more characterizations for the HUVEC layer are yet to be performed.
Permeability of the HUVEC layer is vital to the function of the vasculature. Also,
immunostaining such as CD31 and VE-cadherin could be performed on the HUVEC layer
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to verify cell phenotype and the cell-cell junction. Besides, the HUVEC layer cannot fully
resemble the actual vessel structures, which have multicellular and hierarchical structures
instead of a HUVEC monolayer. For the norbornene-modified CMC bioink platforms, one
significant drawback is the print fidelity. Current ink formulations do not allow printing
self-supportive cCMC/NorCMC without printing support materials. To address this issue,
the in-situ crosslink strategy could be utilized as a potential solution [121]. As to the
polyester-based ink platform with tunable properties, although the bioactivity was tunable,
we did not directly evaluate the bioactivity. Due to our limited access to animal models, in
vivo tests could have been performed to demonstrate the potency of the developed
biomaterial ink. Moreover, thermal degradation should be considered and characterized,
and the mechanical properties of the scaffolds could be tracked during the culture process.
In the final chapter, to study the impact of scaffold architecture on hMSC osteogenesis, we
performed multiple characterizations for osteogenesis. However, most of these were to
probe the overall osteogenic expression of the cells on the scaffolds. This might be the
reason for not to observe any significant difference between the different wavy scaffolds.
More tests at a single cell level could potentially provide more detailed information to
identify the optimal wavy pattern to enhance hMSC osteogenesis. In addition, the strut
size (or the size of the wavy patterns) utilized in this study was much larger than that of a
single cell due to limitations in 3D printing technology, which inherently limits our ability
to create single-cell scale curvature.

113

APPENDIX A
SUPPLEMENTARY DATA OF CHAPTER 2

This appendix includes NMR data and line test data of Pluronic F-127
2

1
MeALG

MeHA

1
2

Figure A.1 1H NMR spectrum of methacrylated hyaluronic acid (MeHA) and
methacrylated alginate (MeAlg). For MeHA, the functionalization was of ~90%,
determined from the integration of the vinyl group (δ=5.8, 1 H and δ=6.25, 1 H) with
respect to the HA backbone (δ=3.20-4.20, 10 H). For MeAlg, the functionalization was of
~72%, determined from integration of vinyl group (δ=5.8, 1H, and δ=6.25, 0.72 H) with
respect to the hydroxyl group in alginate (δ=4.8-5.2 1H).
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A

B

C

Figure A.2 Line test results showing the strut width plotted against print speed and print
pressure for (A) 0.08 mm, (B) 0.10 mm, and (C) 0.16 mm needle from top to bottom,
respectively.
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APPENDIX B
SUPPLEMENTARY DATA OF CHAPTER 3

This appendix includes NMR data and rheological data of cCMC and NorCMC under
UV.

Figure B.1 1H NMR spectra of (A) cCMC and (B) NorCMC.

Figure B.2 Time sweep test of ink formulations under light exposure, (A) 10% NorCMC
1:2 and (B) cCMC 1:2. Green area denotes the UV exposure period.
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Figure B.3 Time sweep test of cCMC (1:2) without pH adjustment.
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APPENDIX C
SUPPLEMENTARY DATA OF CHAPTER 4

C.1 Monomer Synthesis
C.1.1 Synthesis of 4-hydroxyphenethyl 2-(4-hydroxyphenyl)acetate (HTy)
A 2 L round bottom flask was attached to an overhead stirrer and a Dean-Stark apparatus
with water-cooled condenser and a heating mantle was placed beneath the flask. 4hydroxyphenylacetic acid (157.4 g, 1.03 mol), Tyrosol (142.9 g, 1.03 mol), phosphoric
acid (5.07 g, 51.7 mmol), and 315 mL of toluene were added to the flask. The reaction
mixture was stirred and heated at reflux until no more water was collected by azeotropic
distillation. The reaction mixture was allowed to cool and phase separate and the upper
layer was decanted leaving a thick syrup. The syrup was dissolved in 600 mL of ethyl
acetate and washed twice with 150 mL of 5% sodium bicarbonate solution and twice with
150 mL of brine solution. The ethyl acetate solution was dried over magnesium sulfate and
concentrated in vacuo to obtain a thick syrup. The syrup was concentrated in vacuo several
times with cold dichloromethane to obtain a white powdered residue. The powder was
recrystallized from a dichloromethane:hexane mixture, collected by vacuum filtration, and
dried in a vacuum oven at 40 ˚C for 72 h. Yield: 223 g, 79%. Melting Point: 94 ˚C. 1H
NMR (500 MHz, DMSO-d6, δ in ppm): 9.27 (s, 1H), 9.18 (s, 1H), 7.02 - 6.94 (m, 4H), 6.71
- 6.64 (m, 4H), 4.14 (t, J = 6.9 Hz, 2H), 3.48 (s, 2H), 2.74 (t, J = 6.9 Hz, 2H).
C.1.2 Synthesis of Dimethyl hex-5-enoylglutamate (Gluhexenamide dimethylester)
L-glutamic acid dimethyl ester hydrochloride (1.0 g, 4.7 mmol) was mixed with
triethylamine (0.47 g, 4.7 mmol) in 10 mL of dichloromethane (DCM). Separately, 5-
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hexenoic acid (0.59 g, 5.2 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride (EDCI) (0.99 g, 5.2 mmol), and hydroxybenzotriazole monohydrate (HOBt)
(0.80 g, 5.2 mmol) were dissolved in 10 mL DCM. The two solutions were combined and
stirred overnight. The solution was washed twice with 20 mL of 10% sodium bicarbonate
solution, dried over magnesium sulfate, and concentrated in vacuo to obtain an oil that was
used without further purification. Yield: 86 %. 1H NMR (500 MHz, DMSO-d6, δ in ppm):
8.18 (d, J = 7.5 Hz, 1H), 5.77 (ddt, J = 16.9, 10.2, 6.6 Hz, 1H), 5.03 - 4.90 (m, 2H), 4.23
(ddd, J = 9.2, 7.5, 5.3 Hz, 1H), 3.60 (s, 3H), 3.57 (s, 3H), 2.42 - 2.31 (m, 2H), 2.10 (t, J =
7.6 Hz, 2H), 2.02 - 1.90 (m, 3H), 1.79 (dddd, J = 13.8, 9.2, 7.9, 6.6 Hz, 1H), 1.55 (d, J =
7.5 Hz, 2H).
C.1.3 Synthesis of Hex-5-enoylglutamic acid (Gluhexenamide)
Dimethyl hex-5-enoylglutamate (1.1 g, 4.5 mmol) was combined with sodium hydroxide
(0.5 g, 12.5 mmol) in a 3.5:1 tetrahydrofuran:water mixture (7 mL). The resulting solution
was stirred overnight and concentrated in vacuo. The pH was lowered to ~3 by adding
concentrated hydrochloric acid. This solution was extracted with 3 portions of 20 mL ethyl
acetate. The ethyl acetate solution was dried over magnesium sulfate and concentrated in
vacuo. 0.8 g of oily residue was obtained. Yield: 90%. 1H NMR (400 MHz, DMSO-d6, δ
in ppm): 12.40 (s, 2H), 8.02 (d, J = 7.8 Hz, 1H), 5.77 (ddt, J = 16.9, 10.2, 6.6 Hz, 1H), 5.09
- 4.85 (m, 2H), 4.17 (ddd, J = 9.2, 7.9, 5.1 Hz, 1H), 2.28 - 2.20 (m, 2H), 2.14 - 2.07 (m,
2H), 2.03 - 1.87 (m, 3H), 1.79 - 1.66 (m, 1H), 1.61 - 1.49 (m, 2H). ESI-MS m/z: [M-H]Calculated for C11H16NO5- 242.10, found 242.09. ESI-MS: [M+Na]+: Calculated for
C11H17NNaO5 266.10, found 265.98.
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C.1.4 Synthesis of Dimethyl pent-4-ynoylglutamate (Glupentynamide Dimethylester)
L-glutamic acid dimethyl ester hydrochloride (1.0 g, 4.7 mmol) was mixed with
triethylamine (0.47 g, 4.7 mmol) in 10 mL DCM. Separately, 4-pentynoic acid (0.51 g, 5.2
mmol), EDCI (0.99 g, 5.2 mmol), and HOBt (0.80 g, 5.2 mmol) were dissolved in 10 mL
DCM. The two solutions were combined and stirred overnight. The solution was washed
twice with 20 mL of 10% sodium bicarbonate solution, dried over magnesium sulfate, and
concentrated in vacuo to obtain an oil that was used without further purification. Yield:
93 %. 1H NMR (400 MHz, DMSO-d6, δ in ppm): 8.32 (d, J = 7.6 Hz, 1H), 4.28 (td, J =
8.4, 5.4 Hz, 1H), 3.66 - 3.53 (m, 6H), 2.74 (td, J = 2.1, 1.0 Hz, 1H), 2.43 - 2.24 (m, 6H),
1.98 (dtd, J = 13.3, 7.8, 5.3 Hz, 1H), 1.90 - 1.71 (m, 1H).
C.1.5 Synthesis of Pent-4-ynoylglutamic Acid (Glupentynamide)
Dimethyl pent-4-ynoylglutamate (1.1 g, 4.3 mmol) was combined with sodium hydroxide
(0.5 g, 12.5 mmol) in a 3.5:1 tetrahydrofuran:water mixture (7 mL). The resulting solution
was stirred overnight and concentrated in vacuo. The pH was lowered to ~3 by adding
concentrated hydrochloric acid. This solution was extracted with 3 portions of 20 mL ethyl
acetate. The ethyl acetate solution was dried over magnesium sulfate and concentrated in
vacuo to obtain 0.64 g of solid powdered product. Yield: 66 %. Melting Point: 97 ˚C. 1H
NMR (400 MHz, DMSO-d6, δ in ppm): 12.35 (s, 2H), 8.15 (d, J = 7.9 Hz, 1H), 4.20 (ddd,
J = 9.2, 7.8, 5.0 Hz, 1H), 2.77 – 2.68 (m, 1H), 2.43 – 2.18 (m, 6H), 2.03 – 1.84 (m, 1H),
1.83 – 1.65 (m, 1H). ESI-MS m/z: [M+Na]+ Calculated for C10H13NNaO5 250.07, found
250.02; [M+H]+ Calculated for C10H14NO5 228.09, found 227.94.
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C.2 Polymer Synthesis
C.2.1 General Synthesis of Polyesters
In a round bottom flask, 1 equivalent of diol (HTy), 0.97 combined equivalents of diacids,
and 0.33 equivalents of 1,4-dimethylpyridinium p-toluenesulfonate (DPTS) were
combined with DCM and magnetically stirred for 15 min. The stirring reaction mixture
was cooled for 30 min in an ice bath and then 2.1 equivalents of N,N ′ diisopropylcarbodiimide (DIC) were added. The stirring reaction mixture was kept in an
ice bath for 1 hour and then allowed to gradually warm to room temperature overnight.
After 16 hours, the reaction mixture was precipitated by gradually adding isopropanol (5x
DCM volume) while stirring. The precipitate was collected by vacuum filtration,
redissolved in DCM, and reprecipitated using isopropanol twice. The final precipitate was
collected by vacuum filtration and dried in a vacuum oven at 40 ˚C for 48 hours. The
precipitate was analyzed by 1H-NMR, FTIR, GPC, DSC, and TGA.
C.2.2 Synthesis of Poly(HTy-co-50%phenylenediacetate Ester) (HP)
Yield: 88%. GPC: Mn = 84 kDa, Mw = 143 kDa, PDI = 1.7; DSC: Tg = 50 ˚C, Tm1 = 131
˚C, Tm2= 147 ˚C; TGA: Td = 320 ˚C; 1H NMR (500 MHz, DMSO-d6, δ in ppm): 7.35 (s,
4H), 7.22 - 7.18 (m, 4H), 7.03 – 6.99 (m, 4H), 4.21 (t, J = 6.7 Hz, 2H), 3.92 (d, J = 4.4 Hz,
4H), 3.62 (s, 2H), 2.84 (t, J = 6.7 Hz, 2H), (Figure S1); FTIR (ATR) νmax (cm-1): 2917 (w),
1748 (m), 1728 (m), 1606 (w), 1506 (m), 1468 (w), 1422 (w), 1337 (w), 1218 (m), 1193
(m), 1165 (m), 1119 (s), 1017 (m), 915 (m), 807 (w), 788 (w), 689 (w), 648 (w).
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C.2.3

Synthesis

of

Poly(HTy-co-45%phenylenediacetate-co-5%BocGlu

ester)

(HP5BG)
Yield: 94%. GPC: Mn = 80 kDa, Mw = 141 kDa, PDI = 1.8; DSC: Tg = 46 ˚C, Tm1 = 125
˚C, Tm2 = 141 ˚C; TGA: Td = 320 °C; 1H NMR (500 MHz, DMSO-d6, δ in ppm): 7.60 (s,
1H), 7.35 (s, 36H), 7.27 - 7.18 (m, 40H), 7.07 – 6.99 (m, 40H), 4.30 (s, 1H), 4.23 (t, J =
6.6 Hz, 20H), 3.93 (d, J = 4.2 Hz, 36H), 3.64 (s, 20H), 2.86 (t, J = 6.6 Hz, 20H), 2.75 (s,
2H), 2.28 – 2.19 (m, 1H), 2.13 – 2.04 (m, 1H), 1.39 (s, 9H), (Figure S2); FTIR (ATR) νmax
(cm-1): 3035 (w), 2956 (w), 1749 (m), 1731 (m), 1607 (w), 1506 (m), 1423 (w), 1339 (w),
1300 (w), 1218 (m), 1193 (m), 1164 (m), 1120 (s), 1017 (m), 915 (m), 834 (w), 808 (w),
789 (w), 689 (w), 649 (w).
C.2.4 Synthesis of Poly(HTy-co-45%phenylenediacetate-co-5%Gluhexenamide Ester)
(HP5GH)
Yield: 90%. GPC: Mn = 77 kDa, Mw = 126 kDa, PDI = 1.6; DSC: Tg = 47 ˚C, Tm1 = 128
˚C, Tm2 = 143 ˚C; TGA: Td = 320 ˚C; 1H NMR (500 MHz, DMSO-d6, δ in ppm): 8.51 –
8.47 (m, 1H), 7.34 (s, 36H), 7.25 - 7.16 (m, 40H), 7.05 - 6.98 (m, 40H), 5.82 - 5.69 (m,
1H), 5.01 - 4.88 (m, 2H), 4.59 - 4.49 (m, 1H), 4.21 (t, J = 6.6 Hz, 20H), 3.92 (d, J = 4.3
Hz, 36H), 3.62 (s, 20H), 2.84 (t, J = 6.6 Hz, 20H), 2.75 (s, 2H), 2.25 (m, 1H), 2.18 (t, J =
7.3 Hz, 2H), 2.13 - 2.05 (m, 1H), 2.05 - 1.99 (m, 2H), 1.64 - 1.56 (m, 2H), (Figure S3);
FTIR (ATR) νmax (cm-1): 3035 (w), 2955 (w), 1749 (m), 1731 (m), 1674 (w), 1607 (w),
1506 (m), 1423 (w), 1338 (w), 1300 (w), 1218 (m), 1193 (m), 1164 (m), 1120 (s), 1017
(m), 915 (m), 844 (w), 808 (w), 789 (w), 688 (w), 648 (w).
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C.2.5 Synthesis of Poly(HTy-co-45%phenylenediacetate -co-5%Glupentynamide
Ester) (HP5GP)
Yield: 84%. GPC: Mn = 78 kDa, Mw = 129 kDa, PDI = 1.6; DSC: Tg = 50 ˚C, Tm1 = 127
˚C, Tm2 = 144 ˚C; TGA: Td = 320 ˚C; 1H NMR (500 MHz, DMSO-d6, δ in ppm): 8.62 8.58 (m, 1H), 7.34 (s, 36H), 7.25 - 7.17 (m, 40H), 7.06 - 6.98 (m, 40H), 4.59 - 4.52 (m,
1H), 4.21 (t, J = 6.7 Hz, 20H), 3.92 (d, J = 4.3 Hz, 36H), 3.62 (s, 20H), 2.84 (t, J = 6.7 Hz,
20H), 2.80 - 2.70 (m, 3H), 2.41 (s, 4H), 2.30 - 2.22 (m, 1H), 2.13 - 2.04 (m, 1H), (Figure
S4); FTIR (ATR) νmax (cm-1): 3035 (w), 2956 (w), 1749 (m), 1731 (m), 1679 (w), 1607
(w), 1506 (m), 1423 (w), 1379 (w), 1338 (w), 1300 (m), 1218 (m), 1193 (m), 1164 (m),
1120 (s), 1017 (m), 915 (m), 844 (m), 808 (m), 789 (m), 688 (w), 649 (w), 596 (w), 556
(w).

C.3 Functionalization Studies
C.3.1 Bulk Reactivity of HP5GH and HP5GP
A solution of HP5GH (0.2 g in 2 mL DCM) was combined with 65 mg (3 equivalents) of
1H,1H,2H,2H-perflurodecanethiol and 10 mg of Irgacure-2959 (photoinitiator). The
solution was transferred into a quartz cuvette and stirred with a magnetic stirrer. The
solution was stirred under UV light (365 nm) for 5 hours. The solution was then added
dropwise into a stirring solution of isopropanol to precipitate the polymer. The resulting
residue was partially dried and re-dissolved in 2 mL DCM and reprecipitated to wash out
the unreacted thiol. The resulting residue was filtered and dried in a vacuum oven at 40 ˚C.
The reaction product was analyzed by 1H and 19F NMR.
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C.3.2 Surface Reactivity of HP5GH with 1H,1H,2H,2H-perflurodecanethiol
Compression molded films of polymer HP5GH were cut into 5 mm diameter discs. Each
disc was then kept in a Teflon dish and 10 µL solution of Irgacure-2959 in methanol
(MeOH) and a 100 µL solution of 1H,1H,2H,2H-perflurodecanethiol in MeOH were added.
The concentrations of the thiol and Irgacure-2959 are shown in Table C.1. Each film was
then irradiated with UV for a predetermined time. The film was then flipped and identical
amounts of Irgacure-2959 and 1H,1H,2H,2H-perflurodecanethiol were added to the other
side and irradiated with UV. The UV source was kept at a distance of 14 cm and had a
power of 3.6 mW/cm2. For longer UV exposures, 50 µL of fresh MeOH was added on top
to compensate for the loss of solvent due to evaporation. After irradiation of both sides, the
film was transferred to a 1 dram vial and washed with 1 mL MeOH by vortexing for 20
seconds. The MeOH was separated and discarded and the washing was repeated 9 more
time. Finally, each film was sonicated in 1 mL MeOH for 10 min, the MeOH was discarded,
and the film was dried in a vacuum oven for 16 hours. The treated films were mounted on
XPS instrument platform and data was collected for two distinct spots.
C.3.3 Surface Reactivity of HP5GH with Bovine Serum Albumin (BSA)
Two QCM gold plated crystals were spin coated with 2% (w/v) DCM solution of HP5GH
and dried overnight under vacuum. A solution of 100 µl BSA (0.25 mg/mL) was placed on
top of the crystals. To these crystals, a 50 µl solution of Irgacure-2959 (1mg/mL) was
added (Irgacure-2959 was dissolved by stirring in DPBS for 1 hour). One crystal was then
placed under UV light (365 nm) for 5 min and another was kept in dark. Then the crystals
were rinsed by 10 mL DPBS. The crystals were then placed in the QCM chamber and the
frequency was measured while a flow of DPBS was maintained. The frequency data was
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converted to areal mass using the Sauerbrey equation.

C.4 Surface Reactivity of HP5GP with Az-Heparin
C.4.1 Synthesis of Az-Heparin
A batch of 376 mg of Heparin (5 kDa) was combined with 25.9 mg of imidazole sulfonyl
azide tetrafluoroborate, 30 mg of potassium carbonate, and 7.7 mg of copper sulfate
pentahydrate and dissolved in 37.5 mL deionized (DI) water. The reaction was stirred
overnight, then dialyzed for 24 hours using D7884 dialysis membrane from Sigma-Aldrich,
and lyophilized to obtain a white powdered residue.
C.4.2 QCM Experiment of HP5GP with Az-Heparin and BMP-2.
A QCM gold plated crystal was spin coated with 2% (w/v) DCM solution of HP5GP and
dried overnight under vacuum. The polymer coated crystal was then loaded on QSENSE
module and flowed over with DPBS until a stable baseline was achieved. Then a solution
of az-Heparin (1mg/ml) mixed with 0.1 mg copper sulfate pentahydrate and 1 mg of
sodium ascorbate was flowed over the polymer coated QCM crystal until an equilibrium
was reached, then DPBS was flowed over the polymer coated surface to remove the
unreacted az-Heparin. Then a solution of BMP-2 (24 µg/ml) was flowed over the coated
QCM crystal until an equilibrium was reached. Then DPBS solution was flowed over the
QCM crystal.
C.4.3QCM Control Experiment 1: HP5GP/HP + Az-Heparin. A QCM gold plated
crystal was spin coated with 2% (w/v) DCM solution of HP5GP or 2% (w/v) HP and dried
overnight under vacuum. The polymer coated crystal was then loaded on QSENSE module
and flowed over with DI water until a stable baseline was achieved. Then a solution of az-
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Heparin (1mg/ml) mixed with 0.1 mg copper sulfate pentahydrate and 1 mg of sodium
ascorbate was flowed over the polymer coated QCM crystal for 6 hours. Then a solution
of sodium dodecyl sulfate (2% aqueous) was flowed for 30 min followed by DI water
overnight.
C.4.4 QCM Control Experiment 2: HP5GP + BMP-2. A QCM gold plated crystal was
spin coated with 2% (w/v) DCM solution of HP5GP and dried overnight under vacuum.
The polymer coated crystal was then loaded on QSENSE module and flowed over with
DPBS until a stable baseline was achieved. Then a solution of BMP-2 (24 µg/ml) was
flowed over the coated QCM crystal until an equilibrium was reached. Then DPBS solution
was flowed over the QCM crystal.
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Table C.1 The List of Results from Reactions between HP5GP and 1H,1H,2H,2Hperfluorodecanethiol
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Figure C.6 Left: Young’s modulus over time at 37 ˚C in DPBS; Right: Yield strength over
time at 37 ˚C in DPBS.
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1. Az-heparin (1 mg/ml)
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2. 2% SDS
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Figure C.7 Graph of frequency change over time when az-Heparin, 2% SDS, and
DPBS were flowed over a QCM crystal coated with HP5GP.
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